<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5703515</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0188094</article-id><article-id pub-id-type="publisher-id">PONE-D-17-27039</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Chronic Obstructive Pulmonary Disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and Information Sciences</subject><subj-group><subject>Artificial Intelligence</subject><subj-group><subject>Artificial Neural Networks</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Computational Neuroscience</subject><subj-group><subject>Artificial Neural Networks</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Computational Neuroscience</subject><subj-group><subject>Artificial Neural Networks</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Elements</subject><subj-group><subject>Oxygen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Processes</subject><subj-group><subject>Sleep</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Processes</subject><subj-group><subject>Sleep</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Medicine</subject><subj-group><subject>Clinical Neurophysiology</subject><subj-group><subject>Polysomnography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Apnea</subject><subj-group><subject>Sleep Apnea</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Sleep Disorders</subject><subj-group><subject>Sleep Apnea</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Sleep Disorders</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Assessment of automated analysis of portable oximetry as a screening test for moderate-to-severe sleep apnea in patients with chronic obstructive pulmonary disease </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Portable oximetry for OSAS screening in COPD patients</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Andrés-Blanco</surname><given-names>Ana M.</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Álvarez</surname><given-names>Daniel</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Crespo</surname><given-names>Andrea</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Arroyo</surname><given-names>C. Ainhoa</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cerezo-Hernández</surname><given-names>Ana</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gutiérrez-Tobal</surname><given-names>Gonzalo C.</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hornero</surname><given-names>Roberto</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4554-2167</contrib-id><name><surname>del Campo</surname><given-names>Félix</given-names></name><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Pneumology Service, Río Hortega University Hospital, Valladolid, Spain</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Biomedical Engineering Group, University of Valladolid, Valladolid, Spain</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Di Stefano</surname><given-names>Antonino</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Istituti Clinici Scientifici Maugeri, ITALY</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><text><SENT sid="1" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><corresp id="cor001">* E-mail: <email>fsas@telefonica.net</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>12</volume><issue>11</issue><elocation-id>e0188094</elocation-id><history><date date-type="received"><day>19</day><month>7</month><year>2017</year></date><date date-type="accepted"><day>31</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>© 2017 Andrés-Blanco et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Andrés-Blanco et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0188094.pdf"/><abstract><sec id="sec001"><title><text><SENT sid="2" pm="."><plain>Background </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="3" pm="."><plain>The coexistence of obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) leads to increased morbidity and mortality. </plain></SENT>
<SENT sid="4" pm="."><plain>The development of home-based screening tests is essential to expedite diagnosis. </plain></SENT>
<SENT sid="5" pm="."><plain>Nevertheless, there is still very limited evidence on the effectiveness of portable monitoring to diagnose OSAS in patients with pulmonary comorbidities. </plain></SENT>
</text></SecTag></p></sec><sec id="sec002"><title><text><SENT sid="6" pm="."><plain>Objective </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="7" pm="."><plain>To assess the influence of suffering from COPD in the performance of an oximetry-based screening test for moderate-to-severe OSAS, both in the hospital and at home. </plain></SENT>
</text></SecTag></p></sec><sec id="sec003"><title><text><SENT sid="8" pm="."><plain>Methods </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="9" pm="."><plain>A total of 407 patients showing moderate-to-high clinical suspicion of OSAS were involved in the study. </plain></SENT>
<SENT sid="10" pm="."><plain>All subjects underwent (i) supervised portable oximetry simultaneously to in-hospital polysomnography (PSG) and (ii) unsupervised portable oximetry at home. </plain></SENT>
<SENT sid="11" pm="."><plain>A regression-based multilayer perceptron (MLP) artificial neural network (ANN) was trained to estimate the apnea-hypopnea index (AHI) from portable oximetry recordings. </plain></SENT>
<SENT sid="12" pm="."><plain>Two independent validation datasets were analyzed: COPD versus non-COPD. </plain></SENT>
</text></SecTag></p></sec><sec id="sec004"><title><text><SENT sid="13" pm="."><plain>Results </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="14" pm="."><plain>The portable oximetry-based MLP ANN reached similar intra-class correlation coefficient (ICC) values between the estimated AHI and the actual AHI for the non-COPD and the COPD groups either in the hospital (non-COPD: 0.937, 0.909–0.956 CI95%; COPD: 0.936, 0.899–0.960 CI95%) and at home (non-COPD: 0.731, 0.631–0.808 CI95%; COPD: 0.788, 0.678–0.864 CI95%). </plain></SENT>
<SENT sid="15" pm="."><plain>Regarding the area under the receiver operating characteristics curve (AUC), no statistically significant differences (p &gt;0.01) between COPD and non-COPD groups were found in both settings, particularly for severe OSAS (AHI ≥30 events/h): 0.97 (0.92–0.99 CI95%) non-COPD vs. 0.98 (0.92–1.0 CI95%) COPD in the hospital, and 0.87 (0.79–0.92 CI95%) non-COPD vs. 0.86 (0.75–0.93 CI95%) COPD at home. </plain></SENT>
</text></SecTag></p></sec><sec id="sec005"><title><text><SENT sid="16" pm="."><plain>Conclusion </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="17" pm="."><plain>The agreement and the diagnostic performance of the estimated AHI from automated analysis of portable oximetry were similar regardless of the presence of COPD both in-lab and at-home. </plain></SENT>
<SENT sid="18" pm="."><plain>Particularly, portable oximetry could be used as an abbreviated screening test for moderate-to-severe OSAS in patients with COPD. </plain></SENT>
</text></SecTag></p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution>Sociedad Española de Neumología y Cirugía Torácica (ES)</institution></funding-source><award-id>265/2012</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4554-2167</contrib-id><name><surname>del Campo</surname><given-names>Félix</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003329</institution-id><institution>Ministerio de Economía y Competitividad</institution></institution-wrap></funding-source><award-id>RTC-2015-3446-1</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4554-2167</contrib-id><name><surname>del Campo</surname><given-names>Félix</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003329</institution-id><institution>Ministerio de Economía y Competitividad</institution></institution-wrap></funding-source><award-id>TEC2014-53196-R</award-id><principal-award-recipient><name><surname>Hornero</surname><given-names>Roberto</given-names></name></principal-award-recipient></award-group><award-group id="award004"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100008530</institution-id><institution>European Regional Development Fund</institution></institution-wrap></funding-source><award-id>0378_AD_EEGWA_2_P</award-id><principal-award-recipient><name><surname>Hornero</surname><given-names>Roberto</given-names></name></principal-award-recipient></award-group><award-group id="award005"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100008431</institution-id><institution>Consejería de Educación, Junta de Castilla y León</institution></institution-wrap></funding-source><award-id>VA037U16</award-id><principal-award-recipient><name><surname>Hornero</surname><given-names>Roberto</given-names></name></principal-award-recipient></award-group><award-group id="award006"><funding-source><institution>Consejería de Sanidad, Junta de Castilla y León</institution></funding-source><award-id>GRS 752/A/13</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4554-2167</contrib-id><name><surname>del Campo</surname><given-names>Félix</given-names></name></principal-award-recipient></award-group><award-group id="award007"><funding-source><institution>Ministerio de Economía y Competitividad (ES)</institution></funding-source><award-id>IJCI-2014-22664</award-id><principal-award-recipient><name><surname>Álvarez</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><funding-statement>This research has been partially supported by the project 265/2012 of the Sociedad Española de Neumología y Cirugía Torácica (SEPAR), projects RTC-2015-3446-1 and TEC2014-53196-R from the Ministerio de Economía y Competitividad and the European Regional Development Fund (FEDER), and the projects VA037U16 and GRS 752/A/13 from Junta de Castilla y León and FEDER. D. Álvarez was in receipt of a Juan de la Cierva grant IJCI-2014-22664 from the Ministerio de Economía y Competitividad.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="9"/><page-count count="21"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><SecTag type="INTRO"><sec sec-type="intro" id="sec006"><title><text><SENT sid="19" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="20" pm="."><plain>Obstructive sleep apnea syndrome (OSAS) patients suffer from recurrent episodes of airflow limitation due to intermittent complete or partial collapse of the upper airway while sleeping, leading to non-restful sleep and diminished quality of life [1, 2]. </plain></SENT>
<SENT sid="21" pm="."><plain>The burden of OSAS is continuously increasing mainly due to the drawbacks of the standard diagnostic methodology, i.e. in-hospital polysomnography (PSG). </plain></SENT>
<SENT sid="22" pm="."><plain>While being effective, the availability and accessibility of PSG is very limited and it is considered labor-intensive and expensive [3–5]. </plain></SENT>
<SENT sid="23" pm="."><plain>In order to overcome these limitations, several abbreviated tests for OSAS detection have been proposed during the last years. </plain></SENT>
<SENT sid="24" pm="."><plain>The use of portable monitors at home focused the attention of many researchers due to their readiness, simplicity, efficiency, and lower cost [4, 6–10]. </plain></SENT>
<SENT sid="25" pm="."><plain>Nevertheless, most researchers exclude patients with significant cardiovascular and pulmonary comorbidities from the population under study, which is an important limitation in order to generalize the results. </plain></SENT>
<SENT sid="26" pm="."><plain>In fact, a recent report of the American Academy of Sleep Medicine (AASM) does not recommend the use of portable monitoring for OSAS screening in such patients because there is still little if any evidence on its effectiveness [11]. </plain></SENT>
<SENT sid="27" pm="."><plain>However, it is known that the prevalence of both cardiovascular and pulmonary comorbidities is high among sleep apnea patients [12, 13]. </plain></SENT>
<SENT sid="28" pm="."><plain>Moreover, sleep apnea has been closely related with significant decreased health status and quality of life in the presence of such conditions [12–15]. </plain></SENT>
<SENT sid="29" pm="."><plain>Therefore, there is currently an increasing demand for studies focusing on the assessment of home testing algorithms in patients showing significant comorbidities, especially chronic obstructive pulmonary disease (COPD) [10, 16, 17]. </plain></SENT>
</text></p><p><text><SENT sid="30" pm="."><plain>The coexistence of OSAS and COPD, the so-called overlap syndrome, leads to major social and healthcare-related consequences, mostly in the context of cardiovascular disease [15]. </plain></SENT>
<SENT sid="31" pm="."><plain>Patients showing both conditions simultaneously suffer from more severe oxygen desaturations during sleep than those with either COPD or OSAS alone, as well as worse daytime hypoxemia and hypercapnia [13, 15]. </plain></SENT>
<SENT sid="32" pm="."><plain>Therefore, an early diagnosis of OSAS is essential in order to receive an effective treatment and reduce mortality. </plain></SENT>
<SENT sid="33" pm="."><plain>The revised Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines highlight the need for controlling the impact of comorbid conditions [18]. </plain></SENT>
<SENT sid="34" pm="."><plain>Particularly, screening for sleep-related breathing disorders is strongly recommended in COPD patients showing common daytime and/or night symptoms, such as hypersomnolence and frequent sleep arousals [13, 15, 19]. </plain></SENT>
</text></p><p><text><SENT sid="35" pm="."><plain>There are very few studies focused on the evaluation of portable oximetry as an abbreviated test for OSAS detection among patients with concomitant COPD [20–22]. </plain></SENT>
<SENT sid="36" pm="."><plain>These studies analyzed small datasets using substantially different methodologies and settings. </plain></SENT>
<SENT sid="37" pm="."><plain>As a result, contradictory findings are reported. </plain></SENT>
<SENT sid="38" pm="."><plain>Therefore, further research is needed. </plain></SENT>
</text></p><p><text><SENT sid="39" pm="."><plain>Artificial neural networks (ANNs) have demonstrated to be very useful in many applications of medicine and, particularly, in the field of OSAS diagnosis [23–27]. </plain></SENT>
<SENT sid="40" pm="."><plain>In a previous study by our group, we assessed the diagnostic performance of an ANN trained to estimate the apnea-hypopnea index (AHI) of patients suspected of suffering from OSAS using the oximetry signal from a controlled PSG carried out in the hospital [26]. </plain></SENT>
<SENT sid="41" pm="."><plain>In the present study, we propose to use an ANN to estimate the AHI from portable nocturnal oximetry in the presence of COPD. </plain></SENT>
<SENT sid="42" pm="."><plain>Accordingly, our main goal was to design and exhaustively validate the effectiveness of an ANN-based automated test, assessing how the presence of COPD influences the diagnostic performance of portable oximetry monitoring. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="sec007"><title><text><SENT sid="43" pm="."><plain>Materials and methods </plain></SENT>
</text></title><sec id="sec008"><title><text><SENT sid="44" pm="."><plain>Population under study </plain></SENT>
</text></title><p><text><SENT sid="45" pm="."><plain>Fig 1 shows the detailed flowchart of the study. </plain></SENT>
<SENT sid="46" pm="."><plain>Three patient groups were recruited from June 2013 to January 2015 in order to develop our research. </plain></SENT>
<SENT sid="47" pm="."><plain>Firstly, consecutive patients referred to the sleep unit and regardless of suffering from COPD composed our initial training dataset. </plain></SENT>
<SENT sid="48" pm="."><plain>Secondly, consecutive patients without COPD referred to the sleep unit composed the non-COPD validation dataset. </plain></SENT>
<SENT sid="49" pm="."><plain>Finally, consecutive patients referred to the Pneumology outpatient facilities due to COPD and also showing clinical suspicion of OSAS composed the COPD validation dataset. </plain></SENT>
<SENT sid="50" pm="."><plain>Regarding COPD patients, subjects aged ≥35 years old, current or ex-smokers with a smoking history of at least 10 pack/years were considered. </plain></SENT>
<SENT sid="51" pm="."><plain>At the time of COPD diagnosis, complete pulmonary function evaluation (Master screen PFT, Jaeger) was conducted to confirm the disease, including pre- and post-bronchodilator spirometry, lung volumes, and lung diffusion capacity. </plain></SENT>
<SENT sid="52" pm="."><plain>According to GOLD [18], patients showing a post-bronchodilator spirometry with forced expired volume in 1 second to forced vital capacity ratio (FEV1/FVC) &lt;70% were involved in the study. </plain></SENT>
<SENT sid="53" pm="."><plain>Patients with a previous diagnosis and/or treatment for OSAS, additional sleep disorders, and severe cardiovascular diseases were excluded. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0188094.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.g001</object-id><label>Fig 1</label><caption><title><text><SENT sid="54" pm="."><plain>Patient recruitment flowchart. </plain></SENT>
</text></title><p><text><SENT sid="55" pm="."><plain>PSG: polysomnography; TST: total sleep time. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0188094.g001"/></fig></SecTag><p><text><SENT sid="56" pm="."><plain>The Ethics Committee of the Río Hortega University Hospital approved the study (approval number: CEIC 7/13), which was conducted according to the principles expressed in the Declaration of Helsinki. </plain></SENT>
<SENT sid="57" pm="."><plain>All patients were informed to participate in the study and signed an informed consent. </plain></SENT>
</text></p></sec><sec id="sec009"><title><text><SENT sid="58" pm="."><plain>Data collection protocol and sleep studies </plain></SENT>
</text></title><p><text><SENT sid="59" pm="."><plain>All subjects underwent two sleep studies during consecutive nights: (i) supervised portable oximetry simultaneously to in-hospital PSG and (ii) unsupervised portable oximetry at home. </plain></SENT>
<SENT sid="60" pm="."><plain>The sequence of the attended/unattended sleep studies was determined randomly. </plain></SENT>
<SENT sid="61" pm="."><plain>The AHI from in-lab PSG (AHIPSG) was used to confirm OSAS. </plain></SENT>
<SENT sid="62" pm="."><plain>In addition, two different estimations of the AHI were computed from portable oximetry using the proposed ANN: (i) estimated AHI from supervised oximetry in the sleep laboratory (AHIOX-LAB) and (ii) estimated AHI from unattended oximetry at home (AHIOX-HOME). </plain></SENT>
</text></p><p><text><SENT sid="63" pm="."><plain>Standard in-lab PSG was carried out using a polysomnograph E-series by Compumedics (Compumedics Limited, Victoria, Australia). </plain></SENT>
<SENT sid="64" pm="."><plain>Electroencephalogram (F3-A2, F4-A1, C3-A2, C4-A1, Cz-A2, O1-A2, O2-A1), electrooculogram (right and left), electromyogram (chin and both tibias), electrocardiogram, respiratory effort (chest and abdominal), respiration (thermistor and nasal pressure), oximetry (SpO2 and pulse rate), body position, snoring sounds, and video were recorded and stored for offline inspection by a single trained specialist. </plain></SENT>
<SENT sid="65" pm="."><plain>The AASM rules were used to score sleep studies and derive the AHI from each PSG [28]. </plain></SENT>
<SENT sid="66" pm="."><plain>All PSGs with a total sleep time (TST) &lt;3 h due to significant signal loss (artifacts), voluntary termination of the study by the patient, or insufficient data to assess sleep (low sleep efficiency and/or no REM sleep), were withdrawn from the study [29]. </plain></SENT>
</text></p><p><text><SENT sid="67" pm="."><plain>The Nonin WristOx2 3150 (Nonin Medical, Inc., Plymouth, MI, USA) was used to perform portable oximetry both in the hospital facilities and at patients’ home. </plain></SENT>
<SENT sid="68" pm="."><plain>The SpO2 signal were recorded using a finger probe at a sampling rate of 1 sample per second (1 Hz). </plain></SENT>
<SENT sid="69" pm="."><plain>Both oximetry probes, the one corresponding to the PSG and that corresponding to the portable device, were placed on consecutive fingers of the same hand. </plain></SENT>
<SENT sid="70" pm="."><plain>Previously to the unsupervised recording at home, all participants received both verbal and written instructions on how to use the oximeter. </plain></SENT>
<SENT sid="71" pm="."><plain>All portable SpO2 recordings with a total recording time (TRT) &lt;4 h due to significant signal loss (artifacts), premature battery depletion, or voluntary termination of the recording by the patient, were discarded [30]. </plain></SENT>
<SENT sid="72" pm="."><plain>Additionally, patients who did not complete both in-hospital and at-home studies were also withdrawn from the study. </plain></SENT>
</text></p></sec><sec id="sec010"><title><text><SENT sid="73" pm="."><plain>Automated analysis of SpO2 from oximetry </plain></SENT>
</text></title><sec id="sec011"><title><text><SENT sid="74" pm="."><plain>Pre-processing </plain></SENT>
</text></title><p><text><SENT sid="75" pm="."><plain>SpO2 recordings were downloaded from the portable oximeter and processed offline. </plain></SENT>
<SENT sid="76" pm="."><plain>Each recording was scanned and all zero samples and transient deeps due to patient’s movements were removed. </plain></SENT>
<SENT sid="77" pm="."><plain>Additionally, all changes between consecutive samples greater than or equal to 4%/s as well as saturation samples below 20% were considered artifacts and removed from the signal [31]. </plain></SENT>
<SENT sid="78" pm="."><plain>When large segments of consecutive artifacts were removed, the remaining valid sections were linked. </plain></SENT>
<SENT sid="79" pm="."><plain>Linear interpolation was applied if the difference between concatenated samples was ≥4%/s in order to avoid the inclusion of non-natural changes in the SpO2 time series. </plain></SENT>
</text></p></sec><sec id="sec012"><title><text><SENT sid="80" pm="."><plain>Feature extraction </plain></SENT>
</text></title><p><text><SENT sid="81" pm="."><plain>Every overnight oximetric profile was characterized using an initial set of features from complementary approaches (time vs. frequency and linear vs. </plain></SENT>
<SENT sid="82" pm="."><plain>nonlinear), which has demonstrated to be very useful in the context of automated OSAS diagnosis [26, 32–34]. </plain></SENT>
<SENT sid="83" pm="."><plain>A total of 16 variables arranged into 4 feature subsets were computed: time-domain statistics, frequency-domain statistics, conventional spectral measures, and nonlinear measures. </plain></SENT>
<SENT sid="84" pm="."><plain>Statistics and nonlinear methods in the time domain were applied to non-overlapping 512-sample length segments. </plain></SENT>
<SENT sid="85" pm="."><plain>Statistics and conventional measures in the frequency domain were derived from the power spectral density (PSD) function. </plain></SENT>
<SENT sid="86" pm="."><plain>The widely applied Welch’s method (512-sample Hanning window, 50% overlapping, 1024-sample fast Fourier transform) were used to estimate the spectral content of each recording [35]. </plain></SENT>
</text></p><p><text><SENT sid="87" pm="."><plain>Time-domain statistics. The position (central tendency) and shape (width, asymmetry, and peakedness) of the normalized data histogram of saturation amplitudes from each oximetric time series were parameterized by means of the 1st- to 4th-order statistical moments [36], i.e., mean (M1t), variance (M2t), skewness (M3t), and kurtosis (M4t). </plain></SENT>
</text></p><p><text><SENT sid="88" pm="."><plain>Frequency-domain statistics. Similarly, the data histogram of amplitudes from each normalized PSD function was characterized using the 1st- to 4th-order statistical moments, i.e., mean (M1f), variance (M2f), skewness (M3f), and kurtosis (M4f) in the frequency domain. </plain></SENT>
<SENT sid="89" pm="."><plain>In addition, the median frequency (MF) and the spectral entropy (SE) [37] of each PSD were also computed to further characterize the power distribution of the spectrum. </plain></SENT>
</text></p><p><text><SENT sid="90" pm="."><plain>Conventional spectral measures. Common amplitude- and power-based measures were also computed to characterize the severity and recurrence of desaturations. </plain></SENT>
<SENT sid="91" pm="."><plain>The total signal power (PT) as well as the peak amplitude (PA) and relative power (PR) in the frequency band of interest for adult sleep apnea (0.014–0.033 Hz) were obtained [29]. </plain></SENT>
</text></p><p><text><SENT sid="92" pm="."><plain>Nonlinear measures. Sample entropy (SampEn) [38], central tendency measure (CTM) [39], and Lempel-Ziv complexity (LZC) [40] were applied to quantify the irregularity, variability, and complexity of each SpO2 recording, respectively. </plain></SENT>
</text></p></sec><sec id="sec013"><title><text><SENT sid="93" pm="."><plain>Feature selection </plain></SENT>
</text></title><p><text><SENT sid="94" pm="."><plain>The 16 features derived from every oximetric recording compose a feature pattern that characterizes the presence of OSAS on each subject. </plain></SENT>
<SENT sid="95" pm="."><plain>As mentioned, this initial feature set comprises valuable information linked with the disease. </plain></SENT>
<SENT sid="96" pm="."><plain>Nevertheless, an improved as well as reduced feature subset can be derived by applying a feature selection algorithm. </plain></SENT>
<SENT sid="97" pm="."><plain>Previous works have shown that dimensionality reduction algorithms enhances the prediction ability of oximetric features in the context of OSAS diagnosis [32–34]. </plain></SENT>
</text></p><p><text><SENT sid="98" pm="."><plain>In this study, the fast correlation-based filter (FCBF), a filter methodology for feature selection independent of the pattern recognition technique, is applied [41]. </plain></SENT>
<SENT sid="99" pm="."><plain>FCBF has been previously assessed in the context of automated analysis of supervised airflow recordings for OSAS detection [42, 43]. </plain></SENT>
<SENT sid="100" pm="."><plain>FCBF identifies automatically the most relevant and non-redundant features in terms of the symmetrical uncertainty (SU) [41]. </plain></SENT>
<SENT sid="101" pm="."><plain>SU is a normalization of the so-called information gain (IG), which is a measure of predictability based on the information shared between variables. </plain></SENT>
<SENT sid="102" pm="."><plain>Two main variable filtering stages are involved: (i) relevance- and (ii) redundancy-based feature selection. </plain></SENT>
<SENT sid="103" pm="."><plain>Regarding the relevance analysis, the association between each input feature and the severity of the disease was estimated. </plain></SENT>
<SENT sid="104" pm="."><plain>To achieve this goal, the SU between each feature (Xi) and the standard AHI from PSG (Y) was computed as follows [41]: SUi(Xi,Y)=2IGi(Xi,Y)H(Xi)+H(Y),i=1,…,p,(1) where H refers to the widely known Shannon’s entropy. </plain></SENT>
<SENT sid="105" pm="."><plain>According to their degree of relevance, original input features are ranked from the most (higher SUi) to the less (lower SUi) relevant. </plain></SENT>
<SENT sid="106" pm="."><plain>Then, in order to implement the redundancy analysis, SUi,j is computed between each pair of ranked features starting from the most relevant one (i, j = 1, …, p; i &gt; j in the ranking). </plain></SENT>
<SENT sid="107" pm="."><plain>When SUi,j ≥ SUi, the feature j is removed due to redundancy. </plain></SENT>
<SENT sid="108" pm="."><plain>Hence, the final optimum feature subset was composed of the most relevant and non-redundant variables from portable oximetry. </plain></SENT>
</text></p></sec><sec id="sec014"><title><text><SENT sid="109" pm="."><plain>Pattern recognition </plain></SENT>
</text></title><p><text><SENT sid="110" pm="."><plain>ANNs are composed of multiple interconnected nodes, the so-called neurons, arranged in consecutive levels (layers) leading to a highly parallel structure [44]. </plain></SENT>
<SENT sid="111" pm="."><plain>In the OSAS framework, a regression-based ANN is able to estimate the AHI, which is a continuous scalar positive magnitude. </plain></SENT>
<SENT sid="112" pm="."><plain>Accordingly, a single output neuron is used to approximate the target AHI and a linear activation function ranging [0, ∞) is applied to model the regression problem. </plain></SENT>
<SENT sid="113" pm="."><plain>Therefore, the output of a regression MLP ANN is given by [45]: y=f(x,w)=∑j=1NH[ωjgt(∑i=1dωijxi+bj)+b],(2) where d is the number of features in the optimum input pattern from the previous feature selection process, NH is the number of neurons in the hidden layer, ωj is the weight connecting the hidden neuron hj and the output, b is a bias term linked with the output of the network, ωij is the weight connecting the feature i from the input pattern vector with the hidden neuron hj, bj is the bias of the neuron hj in the hidden layer, and gt(·) is the activation function of the neurons in the hidden layer. </plain></SENT>
<SENT sid="114" pm="."><plain>Weights and biases are determined automatically during the iterative learning process according to the maximum likelihood principle [44]. </plain></SENT>
<SENT sid="115" pm="."><plain>In order to avoid overfitting, the widely known weight decay regularization technique was applied [44]. </plain></SENT>
</text></p><p><text><SENT sid="116" pm="."><plain>Model selection, i.e., optimization of the user-dependent input parameters (number of hidden neurons and regularization), was accomplished by leave-one-out cross-validation (loo-cv) in the training dataset. </plain></SENT>
<SENT sid="117" pm="."><plain>The loo-cv procedure was repeated 100 times to avoid a potential bias linked with the random initialization of weights. </plain></SENT>
<SENT sid="118" pm="."><plain>The average intra-class correlation coefficient (ICC) between the estimated AHI and the actual AHI from PSG was used as the metric for model selection. </plain></SENT>
<SENT sid="119" pm="."><plain>Next, the whole training set was used to carry out the learning process. </plain></SENT>
<SENT sid="120" pm="."><plain>Finally, the trained MLP ANN was further assessed using two independent test datasets composed of unseen patients: the non-COPD group and the COPD group. </plain></SENT>
</text></p></sec></sec><sec id="sec015"><title><text><SENT sid="121" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="122" pm="."><plain>The software tools Matlab version R2014a and IBM SPSS version 19 were used for performing signal processing and statistical analyses, respectively. </plain></SENT>
<SENT sid="123" pm="."><plain>A descriptive analysis of clinical and polysomnographic variables of the population under study was accomplished by computing the median and interquartile range (IQR). </plain></SENT>
<SENT sid="124" pm="."><plain>The non-parametric Kruskal-Wallis test was used to search for significant differences among the 3 groups under study for continuous variables, whereas the Chi2 test was used for the categorical ones. </plain></SENT>
<SENT sid="125" pm="."><plain>A p-value &lt;0.01 was considered significant. </plain></SENT>
<SENT sid="126" pm="."><plain>The ICC was computed to measure quantitatively the agreement between the estimated AHI and the actual AHI from PSG. </plain></SENT>
<SENT sid="127" pm="."><plain>In addition, Bland-Altman and Mountain plots were used to assess qualitatively the agreement between both indices taking into account the groups (COPD and non-COPD) and the settings (in-hospital and at-home) under study. </plain></SENT>
</text></p><p><text><SENT sid="128" pm="."><plain>Regarding diagnostic performance assessment, common cutoffs for moderate (AHI ≥15 events/h) and severe (AHI ≥30 events/h) OSAS were studied. </plain></SENT>
<SENT sid="129" pm="."><plain>The following widely known metrics were computed for each cutoff in the independent test datasets: sensitivity (Se), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR+), negative likelihood ratio (LR-), and accuracy (Acc). </plain></SENT>
<SENT sid="130" pm="."><plain>Additionally, the area under the receiving operating characteristics curve (AUC) was computed as overall performance measure independent of a particular cutoff. </plain></SENT>
<SENT sid="131" pm="."><plain>The 95% confidence interval (CI95%) was computed for every metric. </plain></SENT>
<SENT sid="132" pm="."><plain>The recommendations of the STARD task force for reporting diagnostic performance measures in medical research were taken into account [46]. </plain></SENT>
<SENT sid="133" pm="."><plain>Conventional oxygen desaturation indices (ODIs) of 3% (ODI3) and 4% (ODI4) were assessed for comparison purposes. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="sec016"><title><text><SENT sid="134" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="135" pm="."><plain>A total of 407 eligible patients were involved in the study. Fig 1 shows a detailed description of the recruitment process. </plain></SENT>
<SENT sid="136" pm="."><plain>Regarding patients withdrawn from the study, 12 PSGs (2.95%) were discarded due to insufficient total sleep time (TST &lt;3 hours), uncompleted PSG (the patient left the study or did not attend to the sleep unit), or because files were corrupted. </plain></SENT>
<SENT sid="137" pm="."><plain>Similarly, 14 portable SpO2 recordings (3.44%) were removed due to reasons (either technical or human) linked with portable oximetry: 6 supervised in-hospital oximetry (1.45%) and 8 unsupervised at home (1.97%). </plain></SENT>
<SENT sid="138" pm="."><plain>Finally, 193 patients with suspicion of suffering from OSAS and regardless of COPD composed the training dataset, whereas 110 patients composed the non-COPD test set and 68 patients composed the COPD test group. </plain></SENT>
</text></p><p><text><SENT sid="139" pm="."><plain>Anthropometric and clinical characteristics of the population under study are summarized in Table 1. Table 2 shows the polysomnographic variables of every group under study. </plain></SENT>
<SENT sid="140" pm="."><plain>Significant statistical differences between groups were found for CT90, basal, minimum, and average saturation, whereas no significant differences were identified for the ODI3. </plain></SENT>
<SENT sid="141" pm="."><plain>Regarding sleep staging and respiratory-related events, no significant statistical differences were found among patient groups. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0188094.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="142" pm="."><plain>Demographic and clinical characteristics of the patient groups under study. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0188094.t001g" xlink:href="pone.0188094.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>Feature </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>Training </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>Test 1: non-COPD </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>Test 2: COPD </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>p-value </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>Subjects (n) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>193 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>110 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>68 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>Age (years) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>55.0 [18.2] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>55.0 [18.0] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>64.5 [11.0] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>&lt;0.01 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>Males (n) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>148 (76.7%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>76 (69.1%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>60 (88.2%) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>&lt;0.01 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>BMI (Kg/m2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>28.3 [6.2] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>28.6 [5.8] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>29.0 [5.4] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>0.739 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>AHI (events/h) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>33.6 [43.8] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>33.8 [41.1] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>37.8 [45.1] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>0.609 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>AHI ≥5 events/h (n) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>174 (90.2%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>101 (91.8%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>67 (98.5%) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>0.085 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>AHI ≥15 events/h (n) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>143 (74.1%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>81 (73.6%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>52 (76.5%) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>0.907 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>AHI ≥30 events/h (n) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>108 (56.0%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>63 (57.3%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>39 (57.4%) </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>0.966 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><text><SENT sid="188" pm="."><plain>Data are presented as median [interquartile range] for quantitative variables whereas n(%) is used for categorical variables. </plain></SENT>
<SENT sid="189" pm="."><plain>Non-COPD: test dataset composed of patients without chronic obstructive pulmonary disease; COPD: test dataset composed of chronic obstructive pulmonary disease patients; BMI: body mass index; AHI: apnea-hypopnea index. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="pone.0188094.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.t002</object-id><label>Table 2</label><caption><title><text><SENT sid="190" pm="."><plain>Polysomnographic variables of the groups under study: Sleep staging, respiratory related events, and oximetric indexes. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0188094.t002g" xlink:href="pone.0188094.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>Feature </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>Training </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>Test 1: non-COPD </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>Test 2: COPD </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>p-value </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>Sleep efficiency (%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>83.7 [16.6] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>84.9 [16.9] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>77.1 [23.5] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>0.011 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>Stage N1 (%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>14.4 [9.7] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>12.8 [15.2] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>16.2 [14.2] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="205" pm="."><plain>0.076 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="206" pm="."><plain>Stage N2 (%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="207" pm="."><plain>32.1 [13.4] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="208" pm="."><plain>32.4 [14.5] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="209" pm="."><plain>28.6 [12.4] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="210" pm="."><plain>0.053 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="211" pm="."><plain>Stage N3 (%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="212" pm="."><plain>35.8 [17.6] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="213" pm="."><plain>35.2 [21.7] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="214" pm="."><plain>39.0 [17.8] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>0.337 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>REM sleep (%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>15.4 [9.6] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>14.4 [8.9] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>14.6 [9.3] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>0.665 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>Arousal index (events/h) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>30.5 [22.0] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>25.8 [22.9] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>30.7 [15.6] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>0.061 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>AHI (events/h) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>33.6 [43.8] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>33.8 [41.1] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>37.8 [45.1] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>0.609 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>AI (events/h) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>10.9 [30.8] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>10.6 [27.9] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>9.0 [28.1] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>0.934 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>ODI3 (events/h) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>32.7 [41.3] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>35.5 [38.2] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>38.3 [43.1] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>0.509 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>CT90 (%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>10.5 [25.2] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>10.1 [29.9] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>46.2 [66.0] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>&lt;&lt;0.01 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>SpO2 basal </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>94.0 [2.0] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>94.0 [2.0] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>91.0 [3.0] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>&lt;&lt;0.01 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>SpO2 min </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>82.0 [13.0] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>81.0 [10.0] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>78.0 [11.0] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>&lt;0.01 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>SpO2 mean </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>93.0 [3.0] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>93.0 [3.0] </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>90.0 [4.0] </plain></SENT>
</text></td><td align="char" char="." rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>&lt;&lt;0.01 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p><text><SENT sid="261" pm="."><plain>Data are presented as median [interquartile range]. </plain></SENT>
<SENT sid="262" pm="."><plain>Non-COPD: test dataset composed of patients without chronic obstructive pulmonary disease; COPD: test dataset composed of chronic obstructive pulmonary disease patients; REM: rapid eye movement sleep; AHI: apnea-hypopnea index; ODI3: oxygen desaturation index of 3% in the PSG; CT90: percentage of the total sleep time in the PSG with a saturation below 90%; SpO2: blood oxygen saturation; min: minimum value in the overall recording. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="263" pm="."><plain>Table 3 summarizes the characteristics from spirometry of the COPD group. </plain></SENT>
<SENT sid="264" pm="."><plain>According to GOLD stages [18], 23.5% were categorized as GOLD1, 57.4% as GOLD2, 17.6% as GOLD3, and 1.5% as GOLD4. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0188094.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.t003</object-id><label>Table 3</label><caption><title><text><SENT sid="265" pm="."><plain>Common pulmonary functional measures of COPD patients derived from post-bronchodilator spirometry. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0188094.t003g" xlink:href="pone.0188094.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>Measure from post-bronchodilator spirometry </plain></SENT>
</text></th><th align="left" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>Median [IQR] </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>FVC (L) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>2.9 [1.4] </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>FVC (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>81.8 [27.4] </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="272" pm="."><plain>FEV1 (liters) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>1.7 [0.9] </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>FEV1 (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>63.7 [24.4] </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>FEV1/FVC </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>60.6 [14.6] </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>FVC improvement </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>4.0 [7.9] </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>FEV1 improvement </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>4.0 [8.3] </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p><text><SENT sid="282" pm="."><plain>Data are presented as median [interquartile range]. </plain></SENT>
<SENT sid="283" pm="."><plain>IQR: interquartile range; FEV1: forced expiratory volume in one second; FVC: forced vital capacity. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><sec id="sec017"><title><text><SENT sid="284" pm="."><plain>ANN design in the training dataset </plain></SENT>
</text></title><sec id="sec018"><title><text><SENT sid="285" pm="."><plain>In-hospital supervised setting </plain></SENT>
</text></title><p><text><SENT sid="286" pm="."><plain>A total of 9 features were automatically selected from in-lab attended recordings: M1t, M2t, M3t, M4t, MF, PR, SampEn, CTM, and LZC. Fig 2A shows the model selection process for the ANN in the training set using these features. </plain></SENT>
<SENT sid="287" pm="."><plain>The number of neurons in the hidden layer of the optimum ANN from supervised oximetry was NH = 12 and the regularization parameter was set to ν = 1. </plain></SENT>
<SENT sid="288" pm="."><plain>The proposed ANN achieved 0.96 ICC (0.95, 0.97 CI95%) in the whole training dataset. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0188094.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.g002</object-id><label>Fig 2</label><caption><title><text><SENT sid="289" pm="."><plain>Optimization (model selection) of the MLP ANN in the training set. </plain></SENT>
</text></title><p><text><SENT sid="290" pm="."><plain>(A) In-hospital supervised monitoring. </plain></SENT>
<SENT sid="291" pm="."><plain>(B) At-home unattended monitoring. </plain></SENT>
<SENT sid="292" pm="."><plain>ICC: intra-class correlation coefficient; NH: number of neurons in the hidden layer; ν: regularization parameter. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0188094.g002"/></fig></SecTag></sec><sec id="sec019"><title><text><SENT sid="293" pm="."><plain>At-home unsupervised setting </plain></SENT>
</text></title><p><text><SENT sid="294" pm="."><plain>Similarly, a total of 8 features composed the optimum feature subset from unattended recordings at home: M1t, M3t, M4t, SE, PR, SampEn, CTM, and LZC. Fig 2B shows the model selection procedure. </plain></SENT>
<SENT sid="295" pm="."><plain>The optimum ANN from unsupervised oximetry contained NH = 12 hidden neurons and the regularization parameters was ν = 4. </plain></SENT>
<SENT sid="296" pm="."><plain>The proposed ANN reached 0.80 ICC (0.75, 0.85 CI95%) in the whole training set. </plain></SENT>
</text></p></sec></sec><sec id="sec020"><title><text><SENT sid="297" pm="."><plain>Performance assessment in the test datasets </plain></SENT>
</text></title><sec id="sec021"><title><text><SENT sid="298" pm="."><plain>Agreement with AHI from PSG </plain></SENT>
</text></title><p><text><SENT sid="299" pm="."><plain>Table 4 shows the ICC values achieved by the proposed oximetry-based ANNs and conventional ODI3 and ODI4. </plain></SENT>
<SENT sid="300" pm="."><plain>Regarding the AHIOX-LAB from portable oximetry in the hospital setting, ICC values were very similar in the non-COPD (0.937, CI95% 0.909–0.956) and in the COPD (0.936, CI95% 0.899–0.960) groups (S1 and S2 Tables). </plain></SENT>
<SENT sid="301" pm="."><plain>In the same way, ICC values corresponding to AHIOX-HOME from at-home recordings were again similar among non-COPD (0.731, CI95% 0.631–0.808) and COPD (0.788, CI95% 0.678–0.864) patients (S1 and S2 Tables). </plain></SENT>
<SENT sid="302" pm="."><plain>It is important to note that the estimated AHIOX-LAB and AHIOX-HOME reached notably higher agreement with the actual AHI from PSG than conventional ODIs in both settings. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0188094.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.t004</object-id><label>Table 4</label><caption><title><text><SENT sid="303" pm="."><plain>Agreement between estimated AHI using the proposed ANN and conventional ODIs with actual AHI from PSG for the groups and settings under study. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0188094.t004g" xlink:href="pone.0188094.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>Setting </plain></SENT>
</text></th><th align="center" colspan="2" style="background-color:#A6A6A6" rowspan="1"><text><SENT sid="305" pm="."><plain>In-laboratory </plain></SENT>
</text></th><th align="center" colspan="2" style="background-color:#A6A6A6" rowspan="1"><text><SENT sid="306" pm="."><plain>At-home </plain></SENT>
</text></th></tr><tr><th align="left" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>Group </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>non-COPD </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>COPD </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>non-COPD </plain></SENT>
</text></th><th align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>COPD </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1"><text><SENT sid="312" pm="."><plain>Estimated AHI </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>0.937 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>0.936 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>0.731 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>0.788 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>(0.909, 0.956) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>(0.899, 0.960) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>(0.631, 0.808) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>(0.678, 0.864) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="2" colspan="1"><text><SENT sid="321" pm="."><plain>ODI3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>0.904 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>0.892 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>0.536 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>0.670 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>(0.634, 0.960) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>(0.664, 0.952) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>(0.100, 0.751) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>(0.126, 0.856) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="2" colspan="1"><text><SENT sid="330" pm="."><plain>ODI4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>0.745 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>0.693 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>0.403 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>0.518 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>(0, 0.911) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>(0, 0.819) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>(0, 0.676) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>(0, 0.788) </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p><text><SENT sid="339" pm="."><plain>Data are presented as magnitude and 95% confidence interval. </plain></SENT>
<SENT sid="340" pm="."><plain>non-COPD: test dataset composed of patients without chronic obstructive pulmonary disease; COPD: test dataset composed of chronic obstructive pulmonary disease patients; AHI: apnea-hypopnea index; ODI3: oxygen desaturation index of 3% from portable oximetry; ODI4: oxygen desaturation index of 4% from portable oximetry. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="341" pm="."><plain>Fig 3A–3D depict the Bland-Altman agreement plots for the estimated AHI and the standard AHI for the groups under study. </plain></SENT>
<SENT sid="342" pm="."><plain>In the hospital, we can observe in Fig 3A and 3B that the AHIOX-LAB presented a symmetrical behavior and similar dispersion (limits of agreement) in the non-COPD group (confidence interval = 39.12) and in the COPD dataset (confidence interval = 39.24). </plain></SENT>
<SENT sid="343" pm="."><plain>In addition, the AHIOX-LAB showed low bias, i.e., mean difference with the actual AHI, in both groups (non-COPD: 1.30; COPD: 1.60). </plain></SENT>
<SENT sid="344" pm="."><plain>Regarding the data derived from unsupervised recordings at home, the Bland-Altman agreement plots in Fig 3C and 3D show similar dispersion in both datasets (confidence interval: 76.37 in non-COPD and 72.68 in COPD) as well as comparable low bias (averaged mean differences: 0.61 in non-COPD and 0.73 in COPD) for the AHIOX-HOME. </plain></SENT>
<SENT sid="345" pm="."><plain>It is important to highlight that no significant differences were found between non-COPD and COPD groups neither in the hospital (p = 0.33) nor at home (p = 0.48). </plain></SENT>
<SENT sid="346" pm="."><plain>Mountain plots depicted in Fig 4A and 4B confirm these findings. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0188094.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.g003</object-id><label>Fig 3</label><caption><title><text><SENT sid="347" pm="."><plain>Bland-Altman plots showing agreement between estimated AHI from nocturnal oximetry and actual AHI from PSG. </plain></SENT>
</text></title><p><text><SENT sid="348" pm="."><plain>(A) Supervised oximetry in the laboratory for non-COPD subjects. </plain></SENT>
<SENT sid="349" pm="."><plain>(B) Supervised oximetry in the laboratory for COPD patients. </plain></SENT>
<SENT sid="350" pm="."><plain>(C) Unattended oximetry at home for non-COPD subjects. </plain></SENT>
<SENT sid="351" pm="."><plain>(D) Unattended oximetry at home for COPD patients. </plain></SENT>
<SENT sid="352" pm="."><plain>AHIOX-LAB: apnea-hypopnea index from in-hospital oximetry; PSG: polysomnography; in-LAB: supervised setting in the hospital; non-COPD: patients without chronic obstructive pulmonary disease; COPD: patients with chronic obstructive pulmonary disease; AHIOX-HOME: apnea-hypopnea index from at-home oximetry; at-HOME: supervised setting at home. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0188094.g003"/></fig></SecTag><SecTag type="FIG"><fig id="pone.0188094.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.g004</object-id><label>Fig 4</label><caption><title><text><SENT sid="353" pm="."><plain>Mountain plots showing differences between the reference AHI from PSG and the estimated AHI of non-COPD and COPD groups. </plain></SENT>
</text></title><p><text><SENT sid="354" pm="."><plain>(A) Supervised portable oximetry in the hospital simultaneous to PSG. </plain></SENT>
<SENT sid="355" pm="."><plain>(B) Unattended portable oximetry at home in a different night. </plain></SENT>
<SENT sid="356" pm="."><plain>AHIOX-LAB: apnea-hypopnea index from in-hospital oximetry; PSG: polysomnography; non-COPD: patients without chronic obstructive pulmonary disease; COPD: patients with chronic obstructive pulmonary disease; AHIOX-HOME: apnea-hypopnea index from at-home oximetry. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0188094.g004"/></fig></SecTag></sec><sec id="sec022"><title><text><SENT sid="357" pm="."><plain>Diagnostic performance as a screening test for OSAS </plain></SENT>
</text></title><p><text><SENT sid="358" pm="."><plain>Regarding differences between non-COPD and COPD patients in terms of the effectiveness of the simplified oximetry-based test for OSAS, Fig 5 shows the ROC curves for both groups in the hospital and in the unsupervised setting at home. </plain></SENT>
<SENT sid="359" pm="."><plain>Notice that no significant differences were found between the curves of both groups for the cutoffs under study. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0188094.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.g005</object-id><label>Fig 5</label><caption><title><text><SENT sid="360" pm="."><plain>Receiver operating characteristics curves of the estimated AHI. </plain></SENT>
</text></title><p><text><SENT sid="361" pm="."><plain>(A) Supervised portable oximetry in the hospital using a cutoff of AHI ≥15 events/h. </plain></SENT>
<SENT sid="362" pm="."><plain>(B) Supervised portable oximetry in the hospital using a cutoff of AHI ≥30 events/h. </plain></SENT>
<SENT sid="363" pm="."><plain>(C) Unattended portable oximetry at home using a cutoff of AHI ≥15 events/h. </plain></SENT>
<SENT sid="364" pm="."><plain>(D) Unattended portable oximetry at home using a cutoff of AHI ≥30 events/h. </plain></SENT>
<SENT sid="365" pm="."><plain>AHI: apnea-hypopnea index from standard PSG; non-COPD: patients without chronic obstructive pulmonary disease; COPD: patients with chronic obstructive pulmonary disease; AUC: area under the ROC curve. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0188094.g005"/></fig></SecTag><p><text><SENT sid="366" pm="."><plain>Tables 5 and 6 summarize the performance assessment of the MLPOX-LAB and conventional ODIs for the groups under study in the hospital setting. </plain></SENT>
<SENT sid="367" pm="."><plain>For each individual cutoff, the estimated AHIOX-LAB using the proposed MLP ANN reached high similar accuracy both in the non-COPD and the COPD groups (87.3% vs. </plain></SENT>
<SENT sid="368" pm="."><plain>86.8%, and 92.7% vs. </plain></SENT>
<SENT sid="369" pm="."><plain>91.2% for 15 and 30 events/h, respectively). </plain></SENT>
<SENT sid="370" pm="."><plain>On the other hand, conventional ODIs showed notably higher variability between non-COPD and COPD groups. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0188094.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.t005</object-id><label>Table 5</label><caption><title><text><SENT sid="371" pm="."><plain>Diagnostic performance of the proposed MLPOX-LAB and conventional ODIs from in-laboratory portable oximetry (simultaneously to the PSG) in the non-COPD test group. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0188094.t005g" xlink:href="pone.0188094.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="center" colspan="8" style="background-color:#A6A6A6" rowspan="1"><text><SENT sid="372" pm="."><plain>Moderate OSAS (AHI ≥15 events/h) </plain></SENT>
</text></td></tr><tr><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"/><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>Se (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>Sp (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>PPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>NPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>LR+ </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>LR- </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>Acc (%) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="380" pm="."><plain>AHIOX-LAB </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>97.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>58.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="383" pm="."><plain>86.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>89.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>2.36 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>0.04 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>87.3 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>(91.4–99.7) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>(38.9–76.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>(78.1–93.0) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>(66.9–98.7) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>(1.5–3.6) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="393" pm="."><plain>(0.01–0.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>(80.0–92.7) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="395" pm="."><plain>ODI3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>91.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>80.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>NAa </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>0.09 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>93.6 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>(83.2–99.0) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>(63.4–97.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>(0.01–0.17) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>(87.6–99.3) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="410" pm="."><plain>ODI4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>69.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>53.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>NAa </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="416" pm="."><plain>0.31 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>77.3 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>(56.6–81.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>(38.0–69.7) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>(0.19–0.43) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>(67.7–86.5) </plain></SENT>
</text></td></tr><tr><td align="center" colspan="8" style="background-color:#A6A6A6" rowspan="1"><text><SENT sid="425" pm="."><plain>Severe OSAS (AHI ≥30 events/h) </plain></SENT>
</text></td></tr><tr><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"/><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>Se (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>Sp (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>PPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>NPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>LR+ </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>LR- </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="432" pm="."><plain>Acc (%) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="433" pm="."><plain>AHIOX-LAB </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>95.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>89.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>92.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>93.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>8.95 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>0.05 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>92.7 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>(86.7–99.0) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="442" pm="."><plain>(76.9–96.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>(83.0–97.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>(81.7–98.6) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>(3.9–20.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>(0.02–0.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>(86.4–96.4) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="448" pm="."><plain>ODI3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>76.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>75.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>NAa </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>0.24 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>86.4 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>(62.5–88.7) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>(61.7–87.8) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>(0.11–0.38) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>(78.2–93.9) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="463" pm="."><plain>ODI4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>41.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>56.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>NAa </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>0.59 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>66.4 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>(26.4–56.6) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="472" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>(42.8–68.4) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>(0.43–0.74) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>(55.2–76.7) </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p><text><SENT sid="478" pm="."><plain>Data are presented as magnitude and 95% confidence interval. </plain></SENT>
<SENT sid="479" pm="."><plain>AHI: apnea-hypopnea index; Se: sensitivity; Sp: specificity; PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood ratio; LR-: negative likelihood ratio; Acc: accuracy; AHIOX-LAB: estimated AHI from in-laboratory nocturnal oximetry; ODI3: oxygen desaturation index of 3%; ODI4: oxygen desaturation index of 4%. </plain></SENT>
</text></p></fn><fn id="t005fn002"><p><text><SENT sid="480" pm="."><plain>a NA: if Sp = 100%, then LR+ is not defined. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="pone.0188094.t006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.t006</object-id><label>Table 6</label><caption><title><text><SENT sid="481" pm="."><plain>Diagnostic performance of the proposed MLPOX-LAB and conventional ODIs from in-laboratory portable oximetry (simultaneously to the PSG) in the COPD test group. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0188094.t006g" xlink:href="pone.0188094.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="center" colspan="8" style="background-color:#A6A6A6" rowspan="1"><text><SENT sid="482" pm="."><plain>Moderate OSAS (AHI ≥15 events/h) </plain></SENT>
</text></td></tr><tr><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"/><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>Se (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>Sp (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>PPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>NPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>LR+ </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>LR- </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>Acc (%) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="490" pm="."><plain>AHIOX-LAB </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>96.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>56.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>87.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>81.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>2.20 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>0.07 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>86.8 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>(86.8–99.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>(29.9–80.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>(76.3–94.9) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>(48.2–97.7) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>(1.3–3.8) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>(0.02–0.3) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="504" pm="."><plain>(76.5–94.1) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="505" pm="."><plain>ODI3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>88.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>87.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>95.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>70.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>7.08 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>0.13 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>88.2 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>(77.5–98.6) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>(66.7–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>(88.2–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>(43.7–96.3) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="517" pm="."><plain>(2.42–12.13) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>(0.02–0.27) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>(79.1–96.1) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="520" pm="."><plain>ODI4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="521" pm="."><plain>73.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>53.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>NAa </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>0.27 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="527" pm="."><plain>79.4 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>(58.8–87.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>(30.5–75.3) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>(0.13–0.41) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>(68.1–90.4) </plain></SENT>
</text></td></tr><tr><td align="center" colspan="8" style="background-color:#A6A6A6" rowspan="1"><text><SENT sid="535" pm="."><plain>Severe OSAS (AHI ≥30 events/h) </plain></SENT>
</text></td></tr><tr><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"/><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="536" pm="."><plain>Se (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>Sp (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>PPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>NPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>LR+ </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>LR- </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>Acc (%) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="543" pm="."><plain>AHIOX-LAB </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>97.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>82.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>88.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>96.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>5.65 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>0.03 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>91.2 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="551" pm="."><plain>(86.5–99.9) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>(64.2–94.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>(74.9–96.1) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>(79.6–99.9) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>(2.5–12.6) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="556" pm="."><plain>(0.004–0.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>(80.9–95.6) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="558" pm="."><plain>ODI3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>92.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>93.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="561" pm="."><plain>94.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>90.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>13.39 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>0.08 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>92.7 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="566" pm="."><plain>(81.2–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="567" pm="."><plain>(80.8–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="568" pm="."><plain>(85.2–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="569" pm="."><plain>(75.6–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="570" pm="."><plain>(4.50–20.30) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="571" pm="."><plain>(0–0.20) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="572" pm="."><plain>(84.6–99.5) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="573" pm="."><plain>ODI4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="574" pm="."><plain>53.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="575" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="576" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="577" pm="."><plain>61.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="578" pm="."><plain>NAa </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="579" pm="."><plain>0.46 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="580" pm="."><plain>73.5 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="581" pm="."><plain>(33.5–74.0) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="582" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="583" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="584" pm="."><plain>(43.4–79.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="585" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="586" pm="."><plain>(0.26–0.67) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="587" pm="."><plain>(59.2–86.5) </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t006fn001"><p><text><SENT sid="588" pm="."><plain>Data are presented as magnitude and 95% confidence interval. </plain></SENT>
<SENT sid="589" pm="."><plain>AHI: apnea-hypopnea index; Se: sensitivity; Sp: specificity; PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood ratio; LR-: negative likelihood ratio; Acc: accuracy; AHIOX-LAB: estimated AHI from in-laboratory nocturnal oximetry; ODI3: oxygen desaturation index of 3%; ODI4: oxygen desaturation index of 4%. </plain></SENT>
</text></p></fn><fn id="t006fn002"><p><text><SENT sid="590" pm="."><plain>a NA: if Sp = 100%, then LR+ is not defined. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="591" pm="."><plain>Tables 7 and 8 summarize the diagnostic assessment of the MLPOX-HOME and conventional ODIs in the unattended setting at home. </plain></SENT>
<SENT sid="592" pm="."><plain>Regarding the estimated AHI using the proposed MLP ANN, moderate accuracies were achieved in both populations: 78.2% vs. </plain></SENT>
<SENT sid="593" pm="."><plain>75.0%, and 76.4% vs. </plain></SENT>
<SENT sid="594" pm="."><plain>77.9% in non-COPD and COPD groups for cutoffs of 15 and 30 events/h, respectively. </plain></SENT>
<SENT sid="595" pm="."><plain>Imbalance in the sensitivity–specificity pair increased compared to the hospital setting thought remained similar in both patient groups. </plain></SENT>
<SENT sid="596" pm="."><plain>On the other hand, conventional ODI3 and ODI4 showed the common higher specificity inherent to oximetry as well as a notably higher variability between patients with and without COPD. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0188094.t007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.t007</object-id><label>Table 7</label><caption><title><text><SENT sid="597" pm="."><plain>Diagnostic performance of the proposed MLPOX-HOME and conventional ODIs from portable oximetry at home (unattended in a different preceding/consecutive night to PSG) in the non-COPD test group. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0188094.t007g" xlink:href="pone.0188094.t007"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="center" colspan="8" style="background-color:#A6A6A6" rowspan="1"><text><SENT sid="598" pm="."><plain>Moderate OSAS (AHI ≥15 events/h) </plain></SENT>
</text></td></tr><tr><td align="left" style="background-color:#A6A6A6" rowspan="1" colspan="1"/><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="599" pm="."><plain>Se (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="600" pm="."><plain>Sp (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="601" pm="."><plain>PPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="602" pm="."><plain>NPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="603" pm="."><plain>LR+ </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="604" pm="."><plain>LR- </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="605" pm="."><plain>Acc (%) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="606" pm="."><plain>AHIOX-HOME </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="607" pm="."><plain>97.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="608" pm="."><plain>24.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="609" pm="."><plain>78.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="610" pm="."><plain>77.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="611" pm="."><plain>1.29 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="612" pm="."><plain>0.10 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="613" pm="."><plain>78.2 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="614" pm="."><plain>(91.4–99.7) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="615" pm="."><plain>(10.3–43.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="616" pm="."><plain>(68.9–85.8) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="617" pm="."><plain>(40.0–97.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="618" pm="."><plain>(1.0–1.6) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="619" pm="."><plain>(0.02–0.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="620" pm="."><plain>(69.1–84.6) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="621" pm="."><plain>ODI3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="622" pm="."><plain>59.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="623" pm="."><plain>93.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="624" pm="."><plain>96.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="625" pm="."><plain>45.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="626" pm="."><plain>8.59 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="627" pm="."><plain>0.44 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="628" pm="."><plain>68.2 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="629" pm="."><plain>(46.4–71.9) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="630" pm="."><plain>(80.7–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="631" pm="."><plain>(88.3–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="632" pm="."><plain>(30.2–60.1) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="633" pm="."><plain>(2.81–13.66) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="634" pm="."><plain>(0.30–0.60) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="635" pm="."><plain>(57.6–78.3) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="636" pm="."><plain>ODI4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="637" pm="."><plain>45.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="638" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="639" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="640" pm="."><plain>39.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="641" pm="."><plain>NAa </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="642" pm="."><plain>0.54 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="643" pm="."><plain>60.0 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="644" pm="."><plain>(32.7–58.6) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="645" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="646" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="647" pm="."><plain>(26.7–52.3) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="648" pm="."><plain>(-) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="649" pm="."><plain>(0.41–0.67) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="650" pm="."><plain>(49.2–70.4) </plain></SENT>
</text></td></tr><tr><td align="center" colspan="8" style="background-color:#A6A6A6" rowspan="1"><text><SENT sid="651" pm="."><plain>Severe OSAS (AHI ≥30 events/h) </plain></SENT>
</text></td></tr><tr><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"/><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="652" pm="."><plain>Se (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="653" pm="."><plain>Sp (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="654" pm="."><plain>PPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="655" pm="."><plain>NPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="656" pm="."><plain>LR+ </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="657" pm="."><plain>LR- </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="658" pm="."><plain>Acc (%) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="659" pm="."><plain>AHIOX-HOME </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="660" pm="."><plain>81.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="661" pm="."><plain>70.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="662" pm="."><plain>78.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="663" pm="."><plain>73.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="664" pm="."><plain>2.72 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="665" pm="."><plain>0.27 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="666" pm="."><plain>76.4 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="667" pm="."><plain>(69.1–89.8) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="668" pm="."><plain>(55.1–82.7) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="669" pm="."><plain>(66.5–87.7) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="670" pm="."><plain>(58.1–85.4) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="671" pm="."><plain>(1.7–4.3) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="672" pm="."><plain>(0.2–0.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="673" pm="."><plain>(67.3–83.6) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="674" pm="."><plain>ODI3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="675" pm="."><plain>44.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="676" pm="."><plain>97.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="677" pm="."><plain>96.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="678" pm="."><plain>56.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="679" pm="."><plain>20.89 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="680" pm="."><plain>0.57 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="681" pm="."><plain>67.3 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="682" pm="."><plain>(29.3–59.0) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="683" pm="."><plain>(92.9–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="684" pm="."><plain>(86.9–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="685" pm="."><plain>(43.5–69.3) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="686" pm="."><plain>(4.84–18.42) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="687" pm="."><plain>(0.42–0.73) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="688" pm="."><plain>(56.3–77.1) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="689" pm="."><plain>ODI4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="690" pm="."><plain>23.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="691" pm="."><plain>97.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="692" pm="."><plain>93.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="693" pm="."><plain>48.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="694" pm="."><plain>11.19 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="695" pm="."><plain>0.78 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="696" pm="."><plain>55.5 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="697" pm="."><plain>(12.0–36.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="698" pm="."><plain>(92.9–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="699" pm="."><plain>(76.8–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="700" pm="."><plain>(36.6–61.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="701" pm="."><plain>(2.12–11.99) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="702" pm="."><plain>(0.65–0.91) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="703" pm="."><plain>(44.4–66.8) </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t007fn001"><p><text><SENT sid="704" pm="."><plain>Data are presented as magnitude and 95% confidence interval. </plain></SENT>
<SENT sid="705" pm="."><plain>AHI: apnea-hypopnea index; Se: sensitivity; Sp: specificity; PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood ratio; LR-: negative likelihood ratio; Acc: accuracy; AHIOX-HOME: estimated AHI from at-home nocturnal oximetry; ODI3: oxygen desaturation index of 3%; ODI4: oxygen desaturation index of 4%. </plain></SENT>
</text></p></fn><fn id="t007fn002"><p><text><SENT sid="706" pm="."><plain>a NA: if Sp = 100%, then LR+ is not defined. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="pone.0188094.t008" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.t008</object-id><label>Table 8</label><caption><title><text><SENT sid="707" pm="."><plain>Diagnostic performance of the proposed MLPOX-HOME and conventional ODIs from portable oximetry at home (unattended in a different preceding/consecutive night to PSG) in the COPD test group. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0188094.t008g" xlink:href="pone.0188094.t008"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="center" colspan="8" style="background-color:#A6A6A6" rowspan="1"><text><SENT sid="708" pm="."><plain>Moderate OSAS (AHI ≥15 events/h) </plain></SENT>
</text></td></tr><tr><td align="left" style="background-color:#A6A6A6" rowspan="1" colspan="1"/><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="709" pm="."><plain>Se (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="710" pm="."><plain>Sp (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="711" pm="."><plain>PPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="712" pm="."><plain>NPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="713" pm="."><plain>LR+ </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="714" pm="."><plain>LR- </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="715" pm="."><plain>Acc (%) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="716" pm="."><plain>AHIOX-HOME </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="717" pm="."><plain>86.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="718" pm="."><plain>37.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="719" pm="."><plain>81.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="720" pm="."><plain>46.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="721" pm="."><plain>1.39 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="722" pm="."><plain>0.36 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="723" pm="."><plain>75.0 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="724" pm="."><plain>(74.2–94.4) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="725" pm="."><plain>(15.2–64.6) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="726" pm="."><plain>(69.1–90.9) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="727" pm="."><plain>(19.2–74.9) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="728" pm="."><plain>(0.9–2.1) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="729" pm="."><plain>(0.1–0.9) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="730" pm="."><plain>(63.2–83.8) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="731" pm="."><plain>ODI3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="732" pm="."><plain>69.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="733" pm="."><plain>93.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="734" pm="."><plain>97.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="735" pm="."><plain>48.4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="736" pm="."><plain>11.08 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="737" pm="."><plain>0.33 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="738" pm="."><plain>75.0 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="739" pm="."><plain>(54.2–84.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="740" pm="."><plain>(76.8–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="741" pm="."><plain>(90.4–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="742" pm="."><plain>(26.5–70.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="743" pm="."><plain>(2.44–11.36) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="744" pm="."><plain>(0.16–0.52) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="745" pm="."><plain>(62.7–87.2) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="746" pm="."><plain>ODI4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="747" pm="."><plain>48.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="748" pm="."><plain>93.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="749" pm="."><plain>96.2 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="750" pm="."><plain>35.7 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="751" pm="."><plain>7.69 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="752" pm="."><plain>0.55 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="753" pm="."><plain>58.8 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="754" pm="."><plain>(31.3–65.9) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="755" pm="."><plain>(76.8–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="756" pm="."><plain>(85.6–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="757" pm="."><plain>(18.2–54.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="758" pm="."><plain>(1.68–7.80) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="759" pm="."><plain>(0.36–0.77) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="760" pm="."><plain>(44.8–73.4) </plain></SENT>
</text></td></tr><tr><td align="center" colspan="8" style="background-color:#A6A6A6" rowspan="1"><text><SENT sid="761" pm="."><plain>Severe OSAS (AHI ≥30 events/h) </plain></SENT>
</text></td></tr><tr><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"/><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="762" pm="."><plain>Se (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="763" pm="."><plain>Sp (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="764" pm="."><plain>PPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="765" pm="."><plain>NPV (%) </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="766" pm="."><plain>LR+ </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="767" pm="."><plain>LR- </plain></SENT>
</text></td><td align="center" style="background-color:#A6A6A6" rowspan="1" colspan="1"><text><SENT sid="768" pm="."><plain>Acc (%) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="769" pm="."><plain>AHIOX-HOME </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="770" pm="."><plain>84.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="771" pm="."><plain>69.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="772" pm="."><plain>78.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="773" pm="."><plain>76.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="774" pm="."><plain>2.73 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="775" pm="."><plain>0.22 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="776" pm="."><plain>77.9 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="777" pm="."><plain>(69.5–94.1) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="778" pm="."><plain>(49.2–84.7) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="779" pm="."><plain>(63.2–89.7) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="780" pm="."><plain>(56.4–91.0) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="781" pm="."><plain>(1.6–4.8) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="782" pm="."><plain>(0.1–0.5) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="783" pm="."><plain>(67.0–86.8) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="784" pm="."><plain>ODI3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="785" pm="."><plain>61.5 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="786" pm="."><plain>96.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="787" pm="."><plain>96.0 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="788" pm="."><plain>65.1 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="789" pm="."><plain>17.85 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="790" pm="."><plain>0.40 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="791" pm="."><plain>76.5 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="792" pm="."><plain>(42.0–80.0) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="793" pm="."><plain>(88.0–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="794" pm="."><plain>(84.9–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="795" pm="."><plain>(47.2–82.8) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="796" pm="."><plain>(4.15–18.10) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="797" pm="."><plain>(0.21–0.61) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="798" pm="."><plain>(63.9–87.8) </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="2" colspan="1"><text><SENT sid="799" pm="."><plain>ODI4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="800" pm="."><plain>35.9 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="801" pm="."><plain>96.6 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="802" pm="."><plain>93.3 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="803" pm="."><plain>52.8 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="804" pm="."><plain>10.41 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="805" pm="."><plain>0.66 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="806" pm="."><plain>61.8 </plain></SENT>
</text></td></tr><tr><td align="center" rowspan="1" colspan="1"><text><SENT sid="807" pm="."><plain>(17.5–55.0) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="808" pm="."><plain>(88.0–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="809" pm="."><plain>(76.3–100) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="810" pm="."><plain>(36.6–69.2) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="811" pm="."><plain>(1.99–10.50) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="812" pm="."><plain>(0.46–0.87) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="813" pm="."><plain>(47.4–75.9) </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t008fn001"><p><text><SENT sid="814" pm="."><plain>Data are presented as magnitude and 95% confidence interval. </plain></SENT>
<SENT sid="815" pm="."><plain>AHI: apnea-hypopnea index; Se: sensitivity; Sp: specificity; PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood ratio; LR-: negative likelihood ratio; Acc: accuracy; AHIOX-HOME: estimated AHI from at-home nocturnal oximetry; ODI3: oxygen desaturation index of 3%; ODI4: oxygen desaturation index of 4%. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec></sec></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="conclusions" id="sec023"><title><text><SENT sid="816" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="817" pm="."><plain>In the present study, portable oximetry was assessed as a simplified tool for OSAS diagnosis in COPD patients. </plain></SENT>
<SENT sid="818" pm="."><plain>In order to carry out a thorough analysis, portable oximetry was tested both in the hospital and at home. </plain></SENT>
<SENT sid="819" pm="."><plain>In addition, two independent populations were assessed: (i) non-COPD subjects and (ii) COPD patients. </plain></SENT>
<SENT sid="820" pm="."><plain>Our results revealed that no significant differences exist between COPD and non-COPD patients concerning the capability of the proposed ANN from portable oximetry as a screening test for OSAS. </plain></SENT>
</text></p><p><text><SENT sid="821" pm="."><plain>In our aim to maximize the diagnostic ability of portable oximetry, we proposed the automated analysis of oximetric recordings by means of a regression MLP ANN. </plain></SENT>
<SENT sid="822" pm="."><plain>In this regard, ANNs have been widely applied in medical applications to expedite decisions and avoid misdiagnosis. </plain></SENT>
<SENT sid="823" pm="."><plain>Particularly, MLP is probably the most popular ANN and it has demonstrated to be very useful in the framework of OSAS management [23, 24, 26, 47, 48]. </plain></SENT>
<SENT sid="824" pm="."><plain>The study by Marcos et al. [26] supports the usefulness of a regression-based MLP ANN for estimating the AHI using supervised SpO2 recordings from in-hospital PSG. </plain></SENT>
<SENT sid="825" pm="."><plain>In the present study, we assessed the accurateness and reliability of portable oximetry and ANNs to screen for OSAS at COPD patients’ home. </plain></SENT>
</text></p><p><text><SENT sid="826" pm="."><plain>In the context of OSAS detection from oximetry, simpler oximetric indices, such as the average number of desaturations (conventional ODIs), have been proposed [31, 49, 50]. </plain></SENT>
<SENT sid="827" pm="."><plain>Nevertheless, a systematic underestimation of the disease has been reported and the performance notably varies among studies [4, 51, 52]. </plain></SENT>
<SENT sid="828" pm="."><plain>In the present research, we proposed a complex approach based on ANNs. </plain></SENT>
<SENT sid="829" pm="."><plain>Our experiments found that the estimated AHI from the MLP ANN significantly outperformed conventional ODIs in terms of agreement with actual AHI from PSG both in the hospital and at home. </plain></SENT>
<SENT sid="830" pm="."><plain>Furthermore, the ANN reached similar diagnostic performance in non-COPD and COPD groups in both settings (87.3% vs. </plain></SENT>
<SENT sid="831" pm="."><plain>86.8% Acc for AHI ≥15 events/h and 92.7% vs. </plain></SENT>
<SENT sid="832" pm="."><plain>91.2% Acc for AHI ≥30 events/h in the hospital; 78.2% vs. </plain></SENT>
<SENT sid="833" pm="."><plain>75.0% Acc for AHI ≥15 events/h and 76.4% vs. </plain></SENT>
<SENT sid="834" pm="."><plain>77.9% Acc for AHI ≥30 events/h at home), notably more consistent than conventional ODI3 (93.6% vs. </plain></SENT>
<SENT sid="835" pm="."><plain>88.2% Acc for AHI ≥15 events/h and 86.4% vs. </plain></SENT>
<SENT sid="836" pm="."><plain>92.7% Acc for AHI ≥30 events/h in the hospital; 68.2% vs. </plain></SENT>
<SENT sid="837" pm="."><plain>75.0% Acc for AHI ≥15 events/h and 67.3% vs. </plain></SENT>
<SENT sid="838" pm="."><plain>76.5% Acc for AHI ≥30 events/h at home) and ODI4 (77.3% vs. </plain></SENT>
<SENT sid="839" pm="."><plain>79.4% Acc for AHI ≥15 events/h and 66.4% vs. </plain></SENT>
<SENT sid="840" pm="."><plain>73.5% Acc for AHI ≥30 events/h in the hospital; 60.0% vs. </plain></SENT>
<SENT sid="841" pm="."><plain>58.8% Acc for AHI ≥15 events/h and 55.5% vs. </plain></SENT>
<SENT sid="842" pm="."><plain>61.8% Acc for AHI ≥30 events/h at home). </plain></SENT>
<SENT sid="843" pm="."><plain>In addition, once optimized and trained, ANNs are reliable, easy-to-use, and computationally efficient tools, which are major features in order to speed up decision-making. </plain></SENT>
</text></p><p><text><SENT sid="844" pm="."><plain>Pertinent features derived from each overnight oximetric profile fed the neural network. </plain></SENT>
<SENT sid="845" pm="."><plain>Previous studies showed that these variables have high discriminant ability between OSAS-negative and OSAS-positive patients in the context of binary classification from supervised oximetry [32–34]. </plain></SENT>
<SENT sid="846" pm="."><plain>In the present study, we assessed the capability of these features to predict the AHI from portable oximetry. </plain></SENT>
<SENT sid="847" pm="."><plain>The proposed FCBF technique for variable selection automatically identified the features most representative of the actual AHI from PSG (higher symmetrical uncertainty) as well as the less redundant (lower symmetrical uncertainty between each pair of variables). </plain></SENT>
<SENT sid="848" pm="."><plain>It is remarkable that M1t, M3t, M4t, PR, SampEn, CTM, and LZC were all included in the optimum feature subset both in the hospital and at home, which evidences the relevancy of these features in the regression-based ANN for AHI estimation. </plain></SENT>
<SENT sid="849" pm="."><plain>They gather complementary information from the oximetry signal (time: M1t, M3t, M4t; frequency: PR; and nonlinear: SampEn, CTM, and LZC) in order to account for all the changes linked with apneic events which are commonly quantified by means of the AHI. </plain></SENT>
</text></p><p><text><SENT sid="850" pm="."><plain>In regard to the agreement between estimated and actual AHI, a small similar overestimation can be seen for the groups under study both in the hospital (1.30 non-COPD vs. </plain></SENT>
<SENT sid="851" pm="."><plain>1.60 COPD) and at home (0.61 non-COPD vs. </plain></SENT>
<SENT sid="852" pm="."><plain>0.73 COPD). </plain></SENT>
<SENT sid="853" pm="."><plain>Nevertheless, the diagnostic performance did not agree with this slight overall overestimation, as can be derived from Tables 5–8. </plain></SENT>
<SENT sid="854" pm="."><plain>In both settings, higher sensitivity than specificity was obtained for the groups under study, especially for the lower cutoff (AHI ≥15 events/h), which suggests a systemic misclassification into a higher severity group. </plain></SENT>
<SENT sid="855" pm="."><plain>The Bland-Altman plots in Fig 3A and 3B show different trends for low and high AHI values whatever the group or the setting under analysis. </plain></SENT>
<SENT sid="856" pm="."><plain>Significant overestimation was obtained for AHI under 15 events/h, which explains the misclassification towards higher severity classes. </plain></SENT>
<SENT sid="857" pm="."><plain>Conversely, an important underestimation is observed for higher AHI values, which compensates for the initial trend leading to a slight average overestimation. </plain></SENT>
<SENT sid="858" pm="."><plain>It is important to note that this behavior can be observed both in the hospital and at home regardless of suffering from COPD, which agrees with our initial hypothesis. </plain></SENT>
</text></p><p><text><SENT sid="859" pm="."><plain>In our aim to gain insight into the usefulness of at-home portable oximetry for OSAS screening in COPD, a thoroughly analysis of misclassified COPD patients in the unsupervised setting was accomplished. </plain></SENT>
<SENT sid="860" pm="."><plain>Traditionally, it has been suggested that profound nocturnal desaturations characteristic of COPD could lead to increased misdiagnosis in oximetry-based screening tests for OSAS. </plain></SENT>
<SENT sid="861" pm="."><plain>Nevertheless, our findings revealed no influence on the diagnostic capability of oximetry linked with transient worsening due to COPD. </plain></SENT>
<SENT sid="862" pm="."><plain>Furthermore, no differences related to the severity of the pulmonary disease were found among misclassified patients within the COPD group at home. </plain></SENT>
<SENT sid="863" pm="."><plain>Regarding mild COPD (GOLD 1), four patients showing mild OSAS were misclassified as severe using AHIOX-HOME. </plain></SENT>
<SENT sid="864" pm="."><plain>Two patients showed BMI &gt;29 kg/m2 and OSAS was also overestimated using in-laboratory portable oximetry. </plain></SENT>
<SENT sid="865" pm="."><plain>Analyzing the remaining two patients, both were hypertensive and one had a BMI of 50.5 kg/m2. </plain></SENT>
<SENT sid="866" pm="."><plain>In regard to moderate COPD patients (GOLD 2), just one non-OSAS subject (borderline with AHIPSG = 4.2 events/h, obese, and hypertensive) was misclassified as mild OSAS both at home and in the hospital. </plain></SENT>
<SENT sid="867" pm="."><plain>In addition, six OSAS patients were misclassified at home. </plain></SENT>
<SENT sid="868" pm="."><plain>It is important to note that all cases showed significantly decreased (5 patients) or increased (1 patient) number of desaturations in the unattended setting compared to in-hospital recordings, which could be due to the well-known night-to-night variability of OSAS. </plain></SENT>
<SENT sid="869" pm="."><plain>Regarding severe COPD (GOLD 3), four OSAS patients were incorrectly classified into a category of higher severity (3 from mild to moderate and 1 from moderate to severe). </plain></SENT>
<SENT sid="870" pm="."><plain>Two mild OSAS patients showed poor sleep efficiency in the hospital (&lt;55%) and little time in REM sleep, which could hide the actual severity of the disease. </plain></SENT>
<SENT sid="871" pm="."><plain>The moderate OSAS patient showed overweight (BMI = 29.4 kg/m2). </plain></SENT>
<SENT sid="872" pm="."><plain>On the other hand, two severe COPD subjects were wrongly classified at home into an OSAS category of lower severity. </plain></SENT>
<SENT sid="873" pm="."><plain>Both patients showed significant contribution of positional apneas during PSG and they presented markedly low number of desaturations at home due to night-to-night variability. </plain></SENT>
</text></p><p><text><SENT sid="874" pm="."><plain>During the last years, researchers have made a great effort on the development of efficient screening tools for OSAS based on portable monitoring in order to expedite diagnosis. </plain></SENT>
<SENT sid="875" pm="."><plain>Nevertheless, the validation of almost all simplified screening tests excluded patients with significant comorbidities, such as cardiovascular or pulmonary diseases. </plain></SENT>
<SENT sid="876" pm="."><plain>Therefore, data on the accuracy of abbreviated methods in COPD patients are very limited [13, 16, 17]. </plain></SENT>
<SENT sid="877" pm="."><plain>In fact, the AASM does not recommend its use on such populations due to the lack of appropriate evidences supporting their accuracy [11]. Table 9 shows the results reported in the scarce studies where portable monitors are assessed for OSAS screening in COPD patients. </plain></SENT>
<SENT sid="878" pm="."><plain>In the work by Pépin et al. [20], the delta index was proposed to characterize OSAS from portable oximetric recordings acquired in the hospital. </plain></SENT>
<SENT sid="879" pm="."><plain>The authors obtained promising results though a small population composed of only 8 COPD patients was analyzed. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone.0188094.t009" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0188094.t009</object-id><label>Table 9</label><caption><title><text><SENT sid="880" pm="."><plain>Evidences on the effectiveness of portable oximetry monitoring for OSAS detection in patients with COPD in the state-on-the-art and in the present study. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone.0188094.t009g" xlink:href="pone.0188094.t009"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" style="background-color:#BDC0BF" rowspan="1" colspan="1"><text><SENT sid="881" pm="."><plain>Author </plain></SENT>
</text></th><th align="left" style="background-color:#BDC0BF" rowspan="1" colspan="1"><text><SENT sid="882" pm="."><plain>Population </plain></SENT>
</text></th><th align="left" style="background-color:#BDC0BF" rowspan="1" colspan="1"><text><SENT sid="883" pm="."><plain>Method and setting </plain></SENT>
</text></th><th align="left" style="background-color:#BDC0BF" rowspan="1" colspan="1"><text><SENT sid="884" pm="."><plain>Goal </plain></SENT>
</text></th><th align="center" style="background-color:#BDC0BF" rowspan="1" colspan="1"><text><SENT sid="885" pm="."><plain>Se (%) </plain></SENT>
</text></th><th align="center" style="background-color:#BDC0BF" rowspan="1" colspan="1"><text><SENT sid="886" pm="."><plain>Sp (%) </plain></SENT>
</text></th><th align="center" style="background-color:#BDC0BF" rowspan="1" colspan="1"><text><SENT sid="887" pm="."><plain>ICC </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="888" pm="."><plain>Pépin et al. (1991) [20] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="889" pm="."><plain>26 patients 15 OSAS8 COPD3 Restrictive </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="890" pm="."><plain>Method: Delta indexSetting: In-hospital portable oximetry </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="891" pm="."><plain>OSAS detection in: Whole populationPatients showing basal SpO2 &lt;93%COPD patients </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="892" pm="."><plain> 75100100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="893" pm="."><plain> 8683100 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="894" pm="."><plain> --- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="895" pm="."><plain>Oliveira et al. (2012) [21] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="896" pm="."><plain>26 COPD patients showing symptoms of suffering from OSAS </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="897" pm="."><plain>Method: Manual AHISetting. </plain></SENT>
<SENT sid="898" pm="."><plain>SpO2 from RP in-lab and at home </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="899" pm="."><plain>Agreement: PSG vs. </plain></SENT>
<SENT sid="900" pm="."><plain>RPLABPSG vs. </plain></SENT>
<SENT sid="901" pm="."><plain>RPHOMERPLAB vs. </plain></SENT>
<SENT sid="902" pm="."><plain>RPHOME </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="903" pm="."><plain> --- </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="904" pm="."><plain> --- </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="905" pm="."><plain> 0.610.470.47 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="906" pm="."><plain>Scott et al. (2014) [22] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="907" pm="."><plain>59 COPD (GOLD 3–4) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="908" pm="."><plain>Method: Visual and automated analysesSetting: In-hospital portable oximetry </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="909" pm="."><plain>OSAS detection (AHI ≥15) Visual inspectionAutomated ODI4 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="910" pm="."><plain> 5960 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="911" pm="."><plain> 6063 </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="912" pm="."><plain> -- </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="913" pm="."><plain>Present study (2016) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="914" pm="."><plain>371 patients showing symptoms of suffering from OSAS 193 training178 test (110 non-COPD and 68 COPD) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="915" pm="."><plain>Method: Automated analyses by MLP ANNSetting: Portable oximetry in-lab and at home </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="916" pm="."><plain>OSAS detection in the hospital (AHI ≥15): non-COPDCOPDOSAS detection at home (AHI ≥15): non-COPDCOPDAgreement PSG versus MLPOX-LAB in the hospital non-COPDCOPDAgreement PSG versus MLPOX-HOME at home non-COPDCOPD </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="917" pm="."><plain> 97.596.2 97.586.5 -- -- </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="918" pm="."><plain> 58.656.3 24.137.5 -- -- </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="919" pm="."><plain> -- -- 0.940.94 0.730.79 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t009fn001"><p><text><SENT sid="920" pm="."><plain>OSAS: obstructive sleep apnea syndrome; COPD: chronic obstructive pulmonary disease; GOLD: Global Initiative for Chronic Obstructive Lung Disease; AHI: apnea-hypopnea index; SpO2: blood oxygen saturation; RP: respiratory polygraphy; PSG: polysomnography; RPLAB: in-hospital respiratory polygraphy; RPHOME: respiratory polygraphy at home; ODI4: oxygen desaturation index of 4%; MLPOX-LAB: multilayer perceptron artificial neural network trained with oximetric recordings from portable oximetry in the hospital; MLPOX-HOME: multilayer perceptron artificial neural network trained with oximetric recordings from portable oximetry at home. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="921" pm="."><plain>In the study by Oliveira et al. [21], a Type 3 portable monitor was used, which was assessed in a population composed of 26 COPD patients. </plain></SENT>
<SENT sid="922" pm="."><plain>The authors reported a moderate ICC equal to 0.61 between the actual AHI from PSG and manual scoring of in-hospital portable recordings, whereas the agreement decreases up to 0.47 when the monitoring were carried out at home. </plain></SENT>
</text></p><p><text><SENT sid="923" pm="."><plain>In a recent study by Scott et al. [22] a portable oximeter was tested in the hospital to determine the presence or absence of OSAS in 59 COPD patients. </plain></SENT>
<SENT sid="924" pm="."><plain>Using a cutoff of 15 events/h for positive OSAS, visual inspection of the overnight oximetric profile reached 59% Se and 60% Sp, while the performance increased up to 60% Se and 63% Sp using the automated ODI4. </plain></SENT>
</text></p><p><text><SENT sid="925" pm="."><plain>In the present research, additional knowledge is provided on the usefulness of automated processing of portable oximetry as a single tool for screening for OSAS in COPD patients. </plain></SENT>
<SENT sid="926" pm="."><plain>One of the main novelties of our study is that the impact of suffering from COPD on the capability of portable oximetry was assessed by the analysis of two populations: non-COPD and COPD independent test datasets. </plain></SENT>
<SENT sid="927" pm="."><plain>In addition, the proposed methodology based on automated pattern recognition using ANNs was validated both in the hospital and at home. </plain></SENT>
<SENT sid="928" pm="."><plain>Regarding portable monitoring in a supervised setting, our automated approach improved the performance reached by Scott et al. (60% Se– 63% Sp vs. 96.2% Se– 56.3% Sp, AHI ≥15 events/h) [22]. </plain></SENT>
<SENT sid="929" pm="."><plain>On the other hand, our sensitivity–specificity pair showed higher imbalance. </plain></SENT>
<SENT sid="930" pm="."><plain>In the unattended setting, the agreement with the AHI from PSG reported by Oliveira et al. [21] was also notably enhanced (0.47 ICC vs. 0.79 ICC). </plain></SENT>
<SENT sid="931" pm="."><plain>Essential differences between the present research and previous studies account for the dissimilarities in the diagnostic capability of oximetry. </plain></SENT>
<SENT sid="932" pm="."><plain>Firstly, datasets of different size and severity were studied. </plain></SENT>
<SENT sid="933" pm="."><plain>In this regard, it is important to highlight that our sample size is larger than populations analyzed in previous studies and accounts for a wide range of severities in both OSAS and COPD. </plain></SENT>
<SENT sid="934" pm="."><plain>Secondly, there are major methodological differences among studies. </plain></SENT>
<SENT sid="935" pm="."><plain>Previous researchers characterized the portable recording by means of conventional indices, such as the delta index [20] or ODI4 [22], or proposed visual inspection of the overnight oximetric profile [22] or manual scoring of respiratory events [21]. </plain></SENT>
<SENT sid="936" pm="."><plain>On the other hand, our proposal is based on advanced signal processing techniques aimed at deriving as much information as possible from oximetry in order to maximize its diagnostic ability. </plain></SENT>
<SENT sid="937" pm="."><plain>In addition, the most relevant and complementary features were identified and high-performance pattern recognition techniques were used to optimally manage all these data. </plain></SENT>
</text></p><p><text><SENT sid="938" pm="."><plain>Some limitations of the study should be discussed. </plain></SENT>
<SENT sid="939" pm="."><plain>We analyzed a large population of patients showing clinical suspicion of OSAS. </plain></SENT>
<SENT sid="940" pm="."><plain>Particularly, the group composed of patients with concomitant COPD was larger than in previous similar studies aimed at assessing portable oximetry in the presence of comorbidities found in the state-of-the-art. </plain></SENT>
<SENT sid="941" pm="."><plain>Nevertheless, the number of patients with very severe COPD (GOLD 4) could be larger in order to generalize our results. </plain></SENT>
<SENT sid="942" pm="."><plain>Regarding the composition of the population under study, the great imbalance between the number of non-OSAS and OSAS patients is an additional drawback that merits some discussion. </plain></SENT>
<SENT sid="943" pm="."><plain>Sleep apnea patients were predominant, particularly severe OSAS (56.0% of patients in the training set, 57.3% in the non-COPD group, and 57.4% in the COPD group). </plain></SENT>
<SENT sid="944" pm="."><plain>This agrees with the prevalence of the disease reported in similar studies [53]. </plain></SENT>
<SENT sid="945" pm="."><plain>However, this imbalance could influence our results. </plain></SENT>
<SENT sid="946" pm="."><plain>Although we used a regression-based approach and small bias was obtained in the estimation of the AHI from portable oximetry, unbalanced sensitivity-specificity pairs (sensitivity notably higher than specificity) were obtained when using a fixed diagnostic threshold, particularly for the cutoff AHI ≥15 events/h, where the imbalance is more significant. </plain></SENT>
<SENT sid="947" pm="."><plain>While the proposed ANNs could be optimized in future studies using a more balanced population, our models provide interesting insight into the usefulness of portable monitoring for OSAS detection in COPD patients, i.e., oximetry could be an efficient tool as a simplified screening test for OSAS regardless of suffering from COPD. </plain></SENT>
</text></p><p><text><SENT sid="948" pm="."><plain>An additional limitation is linked with conducting the unsupervised oximetry at home and the reference PSG in different nights. </plain></SENT>
<SENT sid="949" pm="."><plain>The night-to-night variability of OSAS is widely known, which could indirectly increase the differences between the actual AHI from PSG and the AHI estimated using portable oximetry at home in a different night. </plain></SENT>
<SENT sid="950" pm="."><plain>Clearly, the agreement between studies conducted simultaneously (PSG and in-lab oximetry) is expected to be higher than the agreement between measures derived from studies performed separately (PSG and at-home oximetry). </plain></SENT>
<SENT sid="951" pm="."><plain>Therefore, the decrease in the agreement between the actual AHI and the estimated AHI from unattended oximetry in the home setting, as well as the decrease in the diagnostic performance, could be mostly due to this issue. </plain></SENT>
<SENT sid="952" pm="."><plain>Nonetheless, both the non-COPD and the COPD groups showed similar behavior and no significant differences were found between groups, which confirm our initial hypothesis. </plain></SENT>
</text></p></sec></SecTag><SecTag type="CONCL"><sec sec-type="conclusions" id="sec024"><title><text><SENT sid="953" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="954" pm="."><plain>A simplified screening test for OSAS based on automated analysis of portable oximetry by means of a regression ANN exhibited no significant differences between non-COPD and COPD patients in terms of diagnostic performance. </plain></SENT>
<SENT sid="955" pm="."><plain>The diagnostic accuracy of the estimated AHI from oximetry and its agreement with the actual AHI from PSG were similar regardless of the presence of COPD both in the laboratory and at home. </plain></SENT>
<SENT sid="956" pm="."><plain>Furthermore, in the home setting, the proposed regression ANN performed similar in patients with such comorbid condition regardless of the severity of COPD, particularly in stages GOLD 1 to 3. </plain></SENT>
<SENT sid="957" pm="."><plain>Our results suggest that automated analysis of unsupervised portable oximetry at home may be recommended as an efficient tool for moderate-to-severe OSAS diagnosis also in the presence of COPD. </plain></SENT>
</text></p></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="sec025"><title><text><SENT sid="958" pm="."><plain>Supporting information </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="pone.0188094.s001"><label>S1 Table</label><caption><title><text><SENT sid="959" pm="."><plain>Actual AHI from PSG, ODI3, ODI4, and estimated AHI from the proposed oximetry-based MLP ANN both in the hospital and at home of each subject in the non-COPD test dataset. </plain></SENT>
</text></title><p><text><SENT sid="960" pm="."><plain>(XLSX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0188094.s001.xlsx"><caption><p><text><SENT sid="961" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0188094.s002"><label>S2 Table</label><caption><title><text><SENT sid="962" pm="."><plain>Actual AHI from PSG, ODI3, ODI4, and estimated AHI from the proposed oximetry-based MLP ANN both in the hospital and at home of each subject in the COPD test dataset. </plain></SENT>
</text></title><p><text><SENT sid="963" pm="."><plain>(XLSX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0188094.s002.xlsx"><caption><p><text><SENT sid="964" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag></body><back><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0188094.ref001"><text><SENT sid="965" pm="."><plain>1YoungT, SkatrudJ, PeppardPE. Risk Factors for obstructive sleep apnea in adults. JAMA. 2009;291:2013–16. </plain></SENT>
</text></ref><ref id="pone.0188094.ref002"><text><SENT sid="966" pm="."><plain>2EpsteinLJ, KristoD, StrolloPJJr, FriedmanN, MalhotraA, PatilSP, et al Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. </plain></SENT>
<SENT sid="967" pm="."><plain>Adult obstructive sleep apnea Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2009;5:263–76. <?supplied-pmid 19960649?>19960649 </plain></SENT>
</text></ref><ref id="pone.0188094.ref003"><text><SENT sid="968" pm="."><plain>3QaseemA, DallasP, OwensDK, StarkeyM, HoltyJEC, ShekelleP. Diagnosis of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161:210–20. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7326/M12-3187">10.7326/M12-3187</ext-link> <?supplied-pmid 25089864?>25089864 </plain></SENT>
</text></ref><ref id="pone.0188094.ref004"><text><SENT sid="969" pm="."><plain>4CollopNA, AndersonWM, BoehleckeB, ClamanD, GoldbergR, GottliebDJ, et al Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. J Clin Sleep Med. 2007;3:737–47. <?supplied-pmid 18198809?>18198809 </plain></SENT>
</text></ref><ref id="pone.0188094.ref005"><text><SENT sid="970" pm="."><plain>5ChiaoW, DurrML. Trends in sleep studies performed for Medicare beneficiaries. Laryngoscope. 2017; In press doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/lary.26736">10.1002/lary.26736</ext-link> <?supplied-pmid 28626986?>28626986 </plain></SENT>
</text></ref><ref id="pone.0188094.ref006"><text><SENT sid="971" pm="."><plain>6Del CampoF, HorneroR, ZamarrónC, AbasoloDE, ÁlvarezD. Oxygen saturation regularity analysis in the diagnosis of obstructive sleep apnea. Artificial Intelligence in Medicine. 2006;37:111–8. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.artmed.2005.10.005">10.1016/j.artmed.2005.10.005</ext-link> <?supplied-pmid 16386411?>16386411 </plain></SENT>
</text></ref><ref id="pone.0188094.ref007"><text><SENT sid="972" pm="."><plain>7NigroCA, DiburE, AimarettiS, GonzálezS, RhodiusE. Comparison of the automatic analysis versus the manual scoring from ApneaLink™ device for the diagnosis of obstructive sleep apnoea syndrome. Sleep and Breathing. 2011;15:679–86. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11325-010-0421-9">10.1007/s11325-010-0421-9</ext-link> <?supplied-pmid 20890768?>20890768 </plain></SENT>
</text></ref><ref id="pone.0188094.ref008"><text><SENT sid="973" pm="."><plain>8MasaJF, Duran-CantollaJ, CapoteF, CabelloM, AbadJ, Garcia-RioF, et al Effectiveness of home single-channel nasal pressure for sleep apnea diagnosis. Sleep. 2014;37:1953–61. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5665/sleep.4248">10.5665/sleep.4248</ext-link> <?supplied-pmid 25325484?>25325484 </plain></SENT>
</text></ref><ref id="pone.0188094.ref009"><text><SENT sid="974" pm="."><plain>9GardeA, DehkordiP, KarlenW, WensleyD, AnserminoJM, DumontGA. Development of a screening tool for sleep disordered breathing in children using the Phone OximeterTM. PLoS One. 2014;9:e112959 doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0112959">10.1371/journal.pone.0112959</ext-link> <?supplied-pmid 25401696?>25401696 </plain></SENT>
</text></ref><ref id="pone.0188094.ref010"><text><SENT sid="975" pm="."><plain>10CorlateanuA, CovantevS, BotnaruV, SircuV, NennaR. To sleep, or not to sleep–that is the question, for polysomnography. Breathe. 2017;13:137–40. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1183/20734735.007717">10.1183/20734735.007717</ext-link> <?supplied-pmid 28620435?>28620435 </plain></SENT>
</text></ref><ref id="pone.0188094.ref011"><text><SENT sid="976" pm="."><plain>11KapurVK, AuckleyDH, ChowdhuriS, KuhlmannDC, MehraR, RamarK, HarrodCG. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13:479–504. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5664/jcsm.6506">10.5664/jcsm.6506</ext-link> <?supplied-pmid 28162150?>28162150 </plain></SENT>
</text></ref><ref id="pone.0188094.ref012"><text><SENT sid="977" pm="."><plain>12SaaresrantaT, HednerJ, BonsignoreMR, RihaRL, McNicholasWT, PenzelT, et al Clinical phenotypes and comorbidity in european sleep apnoea patients. PLoS ONE. 2016;11: e0163439 doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0163439">10.1371/journal.pone.0163439</ext-link> <?supplied-pmid 27701416?>27701416 </plain></SENT>
</text></ref><ref id="pone.0188094.ref013"><text><SENT sid="978" pm="."><plain>13McNicholasWT. COPD-OSA Overlap Syndrome: evolving evidence regarding epidemiology, clinical consequences, and management. Chest. 2017; In press doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chest.2017.04.160">10.1016/j.chest.2017.04.160</ext-link> <?supplied-pmid 28442310?>28442310 </plain></SENT>
</text></ref><ref id="pone.0188094.ref014"><text><SENT sid="979" pm="."><plain>14FlorésM, de BatlleJ, Sánchez-de-la-TorreA, Sánchez-de-la-TorreM, AldomáA, WornerF, et al Central sleep apnoea is related to the severity and short-term prognosis of acute coronary syndrome. PLoS ONE. 2016;11:e0167031 doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0167031">10.1371/journal.pone.0167031</ext-link> <?supplied-pmid 27880845?>27880845 </plain></SENT>
</text></ref><ref id="pone.0188094.ref015"><text><SENT sid="980" pm="."><plain>15MieczkowskiB, EzzieME. Update on obstructive sleep apnea and its relation to COPD. Int J COPD. 2014;9:349–62. </plain></SENT>
</text></ref><ref id="pone.0188094.ref016"><text><SENT sid="981" pm="."><plain>16TreptowE, OliveiraMG, MoreiraGA, TogeiroS, NeryLE, TufikS, BittencourtL. Update on the use of portable monitoring system for the diagnosis of sleep apnea in specific population. World J Respirol 2015; 5(1): 17–27. </plain></SENT>
</text></ref><ref id="pone.0188094.ref017"><text><SENT sid="982" pm="."><plain>17CookseyJA, BalachandranJS. Portable monitoring for the diagnosis of OSA. Chest. 2016;149:1074–81. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1378/chest.15-1076">10.1378/chest.15-1076</ext-link> <?supplied-pmid 26539918?>26539918 </plain></SENT>
</text></ref><ref id="pone.0188094.ref018"><text><SENT sid="983" pm="."><plain>18VogelmeierCF, CrinerGJ, MartinezFJ, AnzuetoA, BarnesPJ, BourbeauJ, et al Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report. Respirology. 2017;22:575–601. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/resp.13012">10.1111/resp.13012</ext-link> <?supplied-pmid 28150362?>28150362 </plain></SENT>
</text></ref><ref id="pone.0188094.ref019"><text><SENT sid="984" pm="."><plain>19HangLW, HsuJY, ChangCJ, WangHC, ChengSL, LinCH, et al Predictive factors warrant screening for obstructive sleep apnea in COPD: a Taiwan National Survey. Int J COPD. 2016;11:665–73. </plain></SENT>
</text></ref><ref id="pone.0188094.ref020"><text><SENT sid="985" pm="?"><plain>20PépinJL, LévyP, LepaulleB, BrambillaC, GuilleminaultC. Does oximetry contribute to the detection of apneic events? </plain></SENT>
<SENT sid="986" pm="."><plain>Mathematical processing of the SaO2 signal. Chest. 1991;99:1151–7. <?supplied-pmid 2019170?>2019170 </plain></SENT>
</text></ref><ref id="pone.0188094.ref021"><text><SENT sid="987" pm="."><plain>21OliveiraMG, NeryLE, Santos-SilvaR, SartoriDE, AlonsoFF, TogeiroSM, et al Is portable monitoring accurate in the diagnosis of obstructive sleep apnea syndrome in chronic pulmonary obstructive disease? Sleep Medicine. 2012;13:1033–8. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.sleep.2012.06.011">10.1016/j.sleep.2012.06.011</ext-link> <?supplied-pmid 22841038?>22841038 </plain></SENT>
</text></ref><ref id="pone.0188094.ref022"><text><SENT sid="988" pm="."><plain>22ScottAS, BaltzanMA, WolkoveN. Examination of pulse oximetry tracings to detect obstructive sleep apnea in patients with advanced chronic obstructive pulmonary disease. Can Respir J. 2014;21:171–5. <?supplied-pmid 24524112?>24524112 </plain></SENT>
</text></ref><ref id="pone.0188094.ref023"><text><SENT sid="989" pm="."><plain>23El-SolhAA, MadorMJ, Ten-BrockE, ShucardDW, Abul-KhoudoudM, GrantBJ. Validity of neural network in sleep apnea. Sleep. 1999;22:105–11. <?supplied-pmid 9989371?>9989371 </plain></SENT>
</text></ref><ref id="pone.0188094.ref024"><text><SENT sid="990" pm="."><plain>24MarcosJV, HorneroR, ÁlvarezD, Del CampoF, ZamarrónC, LópezM. Utility of multilayer perceptron neural network classifiers in the diagnosis of the obstructive sleep apnoea syndrome from nocturnal oximetry. Computer Methods and Programs in Biomedicine. 2008;92:79–89. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cmpb.2008.05.006">10.1016/j.cmpb.2008.05.006</ext-link> <?supplied-pmid 18672313?>18672313 </plain></SENT>
</text></ref><ref id="pone.0188094.ref025"><text><SENT sid="991" pm="."><plain>25AcharyaUR, ChuaECP, FaustO, LimTC, LimLFB. Automated detection of sleep apnea from electrocardiogram signals using nonlinear parameters. Physiological Measurement. 2011;32:287–303. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1088/0967-3334/32/3/002">10.1088/0967-3334/32/3/002</ext-link> <?supplied-pmid 21285482?>21285482 </plain></SENT>
</text></ref><ref id="pone.0188094.ref026"><text><SENT sid="992" pm="."><plain>26MarcosJV, HorneroR, ÁlvarezD, AboyM, Del CampoF. Automated prediction of the apnea-hypopnea index from nocturnal oximetry recordings. IEEE Trans Biomed Eng. 2012;59:141–9. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1109/TBME.2011.2167971">10.1109/TBME.2011.2167971</ext-link> <?supplied-pmid 21926015?>21926015 </plain></SENT>
</text></ref><ref id="pone.0188094.ref027"><text><SENT sid="993" pm="."><plain>27Sánchez-MorilloD, GrossN. Probabilistic neural network approach for the detection of SAHS from overnight pulse oximetry. Med Biol Eng Comput. 2013;51:305 doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11517-012-0995-4">10.1007/s11517-012-0995-4</ext-link> <?supplied-pmid 23160897?>23160897 </plain></SENT>
</text></ref><ref id="pone.0188094.ref028"><text><SENT sid="994" pm="."><plain>28IberC, Ancoli-IsraelS, ChessonA, QuanSF, et al for the American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events-rules, terminology and technical specifications.1st edition Westchester (IL): American Academy of Sleep Medicine; 2007. </plain></SENT>
</text></ref><ref id="pone.0188094.ref029"><text><SENT sid="995" pm="."><plain>29ZamarrónC, GudeF, BarcalaJ, RodriguezJR, RomeroPV. Utility of oxygen saturation and heart rate spectral analysis obtained from pulse oximetric recordings in the diagnosis of sleep apnea syndrome. Chest. 2003;123:1567–76. <?supplied-pmid 12740275?>12740275 </plain></SENT>
</text></ref><ref id="pone.0188094.ref030"><text><SENT sid="996" pm="."><plain>30RedlineS, SandersMH, LindBK, QuanSF, IberC, GottliebDJ, et al for the Sleep Heart Health Research Group. Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep 1998;21:759–68. <?supplied-pmid 11300121?>11300121 </plain></SENT>
</text></ref><ref id="pone.0188094.ref031"><text><SENT sid="997" pm="."><plain>31MagalangUJ, DmochowskiJ, VeeramachaneniS, DrawA, MadorMJ, El-SolhA, et al Prediction of the apnea-hypopnea index from overnight pulse oximetry. Chest 2003;124:1694–701. <?supplied-pmid 14605037?>14605037 </plain></SENT>
</text></ref><ref id="pone.0188094.ref032"><text><SENT sid="998" pm="."><plain>32ÁlvarezD, HorneroR, MarcosJV, Del CampoF. Multivariate analysis of blood oxygen saturation recordings in obstructive sleep apnea diagnosis. IEEE Trans Biomed Eng. 2010;57:2816–24. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1109/TBME.2010.2056924">10.1109/TBME.2010.2056924</ext-link> <?supplied-pmid 20624698?>20624698 </plain></SENT>
</text></ref><ref id="pone.0188094.ref033"><text><SENT sid="999" pm="."><plain>33ÁlvarezD, HorneroR, MarcosJV, Del CampoF. Feature selection from nocturnal oximetry using genetic algorithms to assist in obstructive sleep apnoea diagnosis. Med Eng Phys. 2012;34:1049–57. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.medengphy.2011.11.009">10.1016/j.medengphy.2011.11.009</ext-link> <?supplied-pmid 22154238?>22154238 </plain></SENT>
</text></ref><ref id="pone.0188094.ref034"><text><SENT sid="1000" pm="."><plain>34AlvarezD, HorneroR, MarcosJV, WesselN, PenzelT, GlossM, Del CampoF. Assessment of feature selection and classification approaches to enhance information from overnight oximetry in the context of sleep apnea diagnosis. Int J Neural Sys. 2013;23:1–18. </plain></SENT>
</text></ref><ref id="pone.0188094.ref035"><text><SENT sid="1001" pm="."><plain>35WelchP. The use of fast Fourier transform for the estimation of power spectra: a method based on time averaging over short, modified periodograms. IEEE Trans Acous Speech. 1967;15:70–3. </plain></SENT>
</text></ref><ref id="pone.0188094.ref036"><text><SENT sid="1002" pm="."><plain>36JobsonJD. Applied multivariate data analysis Volume I: Regression and experimental design. New York: Eds. Springer-Verlag; 1991. </plain></SENT>
</text></ref><ref id="pone.0188094.ref037"><text><SENT sid="1003" pm="."><plain>37PozaJ, HorneroR, AbásoloDE, FernándezA, GarcíaM. Extraction of spectral based measures from MEG background oscillations in Alzheimer’s disease. Med Eng Phys. 2007;29:1073–83. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.medengphy.2006.11.006">10.1016/j.medengphy.2006.11.006</ext-link> <?supplied-pmid 17204443?>17204443 </plain></SENT>
</text></ref><ref id="pone.0188094.ref038"><text><SENT sid="1004" pm="."><plain>38RichmanJS, MoormanJR. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol. 2000;278:H2039–49. <?supplied-pmid 10843903?>10843903 </plain></SENT>
</text></ref><ref id="pone.0188094.ref039"><text><SENT sid="1005" pm="."><plain>39CohenME, HudsonDL, DeedwaniaPC. Applying continuous chaotic modeling to cardiac signals. IEEE Eng Med Biol. 1996;15:97–102. </plain></SENT>
</text></ref><ref id="pone.0188094.ref040"><text><SENT sid="1006" pm="."><plain>40ZhangX-S, RoyJR, JensenEW. EEG complexity as a measure of depth of anesthesia for patients. IEEE Trans Biomed Eng. 2001;48:1424–33. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1109/10.966601">10.1109/10.966601</ext-link> <?supplied-pmid 11759923?>11759923 </plain></SENT>
</text></ref><ref id="pone.0188094.ref041"><text><SENT sid="1007" pm="."><plain>41YuL, LiuH. Efficient feature selection via analysis of relevance and redundancy. J Mach Learn Res. 2004;5:1205–24. </plain></SENT>
</text></ref><ref id="pone.0188094.ref042"><text><SENT sid="1008" pm="."><plain>42Gutiérrez-TobalGC, ÁlvarezD, MarcosJV, Del CampoF, HorneroR. Pattern recognition in airflow recordings to assist in the sleep apnoea–hypopnoea syndrome diagnosis. Med Biol Eng Comput. 2013;51:1367–80. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11517-013-1109-7">10.1007/s11517-013-1109-7</ext-link> <?supplied-pmid 24057145?>24057145 </plain></SENT>
</text></ref><ref id="pone.0188094.ref043"><text><SENT sid="1009" pm="."><plain>43Gutiérrez-TobalGC, AlvarezD, Del CampoF, HorneroR. Utility of AdaBoost to detect sleep apnea-hypopnea syndrome from single-channel airflow. IEEE Trans Biomed Eng. 2016;63:636–46. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1109/TBME.2015.2467188">10.1109/TBME.2015.2467188</ext-link> <?supplied-pmid 26276985?>26276985 </plain></SENT>
</text></ref><ref id="pone.0188094.ref044"><text><SENT sid="1010" pm="."><plain>44BishopCM. Pattern recognition and machine learning. New York: Springer; 2006. </plain></SENT>
</text></ref><ref id="pone.0188094.ref045"><text><SENT sid="1011" pm="."><plain>45NabneyIT. NETLAB: Algorithms for Pattern Recognition. Berlin: Springer; 2002. </plain></SENT>
</text></ref><ref id="pone.0188094.ref046"><text><SENT sid="1012" pm="."><plain>46BossuytPM, ReitsmaJB, BrunsDE, GatsonisCA, GlasziouPP, et al for the STARD Group. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Radiology 2015;277:826–32. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1148/radiol.2015151516">10.1148/radiol.2015151516</ext-link> <?supplied-pmid 26509226?>26509226 </plain></SENT>
</text></ref><ref id="pone.0188094.ref047"><text><SENT sid="1013" pm="."><plain>47MarcosJV, HorneroR, ÁlvarezD, Del CampoF, AboyM. Automated detection of obstructive sleep apnoea syndrome from oxygen saturation recordings using linear discriminant analysis. Med Biol Eng Comput. 2010;48:895–902. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11517-010-0646-6">10.1007/s11517-010-0646-6</ext-link> <?supplied-pmid 20574725?>20574725 </plain></SENT>
</text></ref><ref id="pone.0188094.ref048"><text><SENT sid="1014" pm="."><plain>48KaramanliH, YalcinozT, YalcinozMA, YalcinozT. A prediction model based on artificial neural networks for the diagnosis of obstructive sleep apnea. Sleep Breath. 2016;20:509–14. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11325-015-1218-7">10.1007/s11325-015-1218-7</ext-link> <?supplied-pmid 26087718?>26087718 </plain></SENT>
</text></ref><ref id="pone.0188094.ref049"><text><SENT sid="1015" pm="."><plain>49ChungF, LiaoP, ElsaidH, IslamS, ShapiroC, et al Oxygen desaturation index from nocturnal oximetry: a sensitive and specific tool to detect sleep-disordered breathing in surgical patients. Anesth. </plain></SENT>
<SENT sid="1016" pm="."><plain>Analg. 2012;114:993–1000. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1213/ANE.0b013e318248f4f5">10.1213/ANE.0b013e318248f4f5</ext-link> <?supplied-pmid 22366847?>22366847 </plain></SENT>
</text></ref><ref id="pone.0188094.ref050"><text><SENT sid="1017" pm="."><plain>50JungDW, HwangSH, ChoJ, ChoiBH, BaekHJ, et al Real-time automatic apneic event detection using nocturnal pulse oximetry. IEEE Trans. </plain></SENT>
<SENT sid="1018" pm="."><plain>Biomed. </plain></SENT>
<SENT sid="1019" pm="."><plain>Eng. 2017; In press. </plain></SENT>
</text></ref><ref id="pone.0188094.ref051"><text><SENT sid="1020" pm="."><plain>51NetzerN, EliassonAH, NetzerC, KristoDA. Overnight pulse oximetry for sleep-disordered breathing in adults: A review. Chest 2001;120:625–33. <?supplied-pmid 11502669?>11502669 </plain></SENT>
</text></ref><ref id="pone.0188094.ref052"><text><SENT sid="1021" pm="."><plain>52DawsonA, LovingRT, GordonRM, AbelSL, LoewyD, et al Type III home sleep testing versus pulse oximetry: is the respiratory disturbance index better than the oxygen desaturation index to predict the apnoea-hypopnoea index measured during laboratory polysomnography?. BMJ Open 2015;5:e007956 doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmjopen-2015-007956">10.1136/bmjopen-2015-007956</ext-link> <?supplied-pmid 26129636?>26129636 </plain></SENT>
</text></ref><ref id="pone.0188094.ref053"><text><SENT sid="1022" pm="."><plain>53MasaJF, CorralJ, PereiraR, Duran-CantollaJ, CabelloM, Hernández-BlascoL, et al Effectiveness of sequential automatic-manual home respiratory polygraphy scoring. Eur Respir J. 2013;41:879–87. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1183/09031936.00186811">10.1183/09031936.00186811</ext-link> <?supplied-pmid 22878873?>22878873 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
